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INTRODUCTION 
 
"¸í¨¸º¨¼ì ¸É¢ó¾ÀÃ É£ýÈ ¾ó¾¢ì 
¸½À¾¢Â¢ý È¡û Å½í¸¢ì ¸ÕòÐû¨ÅòÐ§¾ 
¦Âí¸ûÀ¢Ã¡ý §ÅøÓÕ¸ý À¡¾õ §À¡üÈ¢ 
¦Â¨ÉÂ¡Ùõ ÀÃ¡ºì¾¢ Â¢Õ¾¡û §À¡üÈ¢ 
Áí¸ÇÁ¡ó ¾òÐÅá Ä¡Ôû §Å¾ 
Á¡ãÄ¢ Å¡¸¼í¸ Ç¡öóÐ §¿¡ì¸¢ 
Âí¸ÓÚ Á¢óá¨Ä ÅºÉÁ¡¸ 
Å¨ÉÅ÷¸Ù ÁÉÁ¸¢Æ Å¨ÃÌ §Å§É”  
     - ¯Â¢÷¸¡ìÌõ º¢ò¾ÁÕòÐÅõ 
 
Nature cures everything 
-  Hippocrates 
Siddha system of medicine, well known for its simplicity and 
credibility has been evolved by spiritual scientists called siddhars. 
“Health is Wealth” 
Of all the wealth Man can gain, the most precious is 
being free from disease.   
Health is defined by the World Health Organization as the 
“State of complete physical, mental and social well being and not 
merely the absence of disease and infirmity”. 
 
The siddha system has been serving the mankind from time 
immemorial by providing remedy to diseases of all system of the 
human body.  
The advantage and unique feature is the removal of the root 
causes of the disease and perfect remedy for body & mind. 
 
 2
"¦º¡øÄ¢¼§Å §¾Å¢ìÌî º¾¡º¢ÅýÈ¡ý 
¦º¡øÄ§Å §¾Å¢Ôõ ¿ó¾¢ìÌî ¦º¡øÄ 
¿øÄ¢¼§Å ¿ó¾¢¾ý Åó¾¢Ã¢ìÌî ¦º¡øÄ 
¿ÂÓ¼ý ¾ýÅó¾¢Ã¢ ÂÍÅÉ¢ìÌî ¦º¡øÄ 
«øÄ¢¼§Å ÂÍÅ¾¢Â¡ó §¾Å÷ ¾¡Óõ 
«¸ò¾¢Â÷ì Ì¨Ãò¾¢¼§Å ÂõÓ É£ó¾¢Ãý 
ÒøÄ¢¼§Å ÒÄò¾¢Â÷ì ÌÀ§¾ º¢ì¸ 
ÒÄò¾¢ÂÕõ §¾¨ÃÂüÌô Ò¸ýÈ¢ð ¼¡§Ã" 
   - ä¸¢¨Åò¾¢Â º¢ó¾¡Á½¢ ±ñßÚ 
The above verse reveals the history of siddha medicine. Our 
system of medicine is closely related to religion. 
 
“Science without religion is blind and 
Religion without science is lame” 
       - Albert Einsteen 
Siddha medicines are very effective in treating chronic 
diseases and particularly skin diseases. That’s why I have selected 
one of the skin diseases ‘vatha karappan’ as my dissertation topic. 
In Yugi Munivar Vaidhya Chindhamani, Karappan is 
classified into 7 types. Vatha karappan comes under this 
classification. 
Skin is one of the components of Prithvi (earth) and this is 
indicated in sathakanadi.  
 
"§ºÃôÀ¡ º¼Á¡îÍ Áñ½¢ý ÜÚ 
 ¦ºÈ¢ÁÂ¢÷ §¾¡ø ±ÖõÀ¢¨Èîº¢ ¿Ãõ¨Àó¾¡Ìõ" 
                  - º¾¸¿¡Ê 
                      §¾¡ø = Áñ + §¾Ô 
 
So any dearrangement in Theyu and its components may 
affect the skin by disturbing the functions of  saaram, senneer, oon 
and kozhuppu. 
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Man highly reflects his surroundings. The components of 
pancha pootha that constitute the universe are the same 
components which constitute human body. This is indicated by 
siddhars as given below;  
 
"«ñ¼ò¾¢ÖûÇ§¾ À¢ñ¼õ 
À¢ñ¼ò¾¢ÖûÇ§¾ «ñ¼õ 
«ñ¼Óõ À¢ñ¼Óõ ´ý§È 
«È¢óÐ¾¡ý À¡÷ìÌõ §À¡§¾" 
    - ºð¼ÓÉ¢ »¡Éõ. 
 
Skin acts as a linking media between our body and the outer 
world. The skin is the first organ affected by any change in the 
universe. 
Because the skin is closely related to the mind, even the   
slightest distress (or) strain of the mind will be reflected by skin, in 
the form of itching and so on. 
 
"§Å÷ À¡Õ ¾¨ÆÀ¡Õ Á¢ïº¢Éì¸¡ø ¦ÁøÄ ¦ÁøÄ  
 ÀüÀ ¦ºóàÃõ À¡§Ã" 
 
Herbs are astonishingly accurate and safe. They also reduce 
the recurrence of attacks. So the author has selected a herbal drug 
for vatha karappan. 
The author hopes that this work on “Vatha Karappan” would 
provide better information by the clinical trial with selected drugs. 
This is only a preliminary study. 
Drugs of choice: 
1. Internal Use :  
Vatha Karappan Chooranam 1-2 gm (Twice a day 
Morning & Evening  with palm jaggary). 
2. External use :  
Aamanakku  Ennai (Mkzf;F ±ñ¦½ö). 
 
AIM AND OBJECTIVES 
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The aim of this dissertation is to study the effect of the drugs, 
ie,vatha karappan chooranam (Internal) amanakku ennai (External)  
on the course of the disease “Vatha Karappan’. 
 
 To know about the incidence of disease in people of different 
age, life style, occupation, socio-economical status, family 
history and also the impact of seasonal variations. 
 
 To know how the disease alters the normal conditions with 
reference to Mukkutram, Poripulangal, Envagai thervugal, 
Ezhu udar kattugal, Neerkuri and Neikuri. 
 
“Several tons of theory can not equal an ounce of 
practice” 
– Swami Sivanandha. 
 To do the bio-chemical analysis, pharmacological and micro 
biological studies of the trial drugs. 
 
 To use the modern parameters to confirm the diagnosis and 
follow the prognosis of the disease. 
 
 To produce an awareness among the people about the 
prevention and to avoid further recurrence of disease by 
personal hygienic measures. 
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 SIDDHA ASPECTS 
 
Neha; ,ay;: (Definition)  
§¾¡Ä¢ø ¾¢Á¢÷ ÌÕ, Òñ, ¾ÊôÒ ¬¸¢Â ÌÈ¢Ì½í¸¨Ç ¯¨¼Â À¨¼¸¨Ç ¯ñ¼¡ì¸¢, 
«ùÅ¢¼í¸Ç¢ø Å£ì¸õ, ¦¸¡ôÒÇí¸û ¸ñÎ «øÄÐ ¦º¾¢ø §À¡ýÚ §¾¡ø ÍÃÍÃôÀ¡¸¢, §¾¡Ä¢ý 
þÂü¨¸ ¿¢Èò¨¾ §ÅÚÀÎò¾¢ º¢Ä§Å¨Ç ¦ÅÊôÒñ¼¡ì¸¢ ¿£÷ ¸º¢¾ø ¬¸¢Â ÌÈ¢Ì½í¸¨Ç 
¸¡ðÎõ §¾¡üÀ¢½¢¨Â ¸ÃôÀ¡ý «øÄÐ ¸ÃôÀý ±ýÚ ÜÚÅ÷. 
 
Neha; tUk; top: (Aetiology) 
 ‘Vohd fug;ghdpd; cw;gj;jpf; Nfsha; 
  Vw;wkha; khkprq;fs; Grpf;ifahYk;> 
 $ohd fk;Gjpid tuF rhik   
  nghbjhd fpoq;Ftif aUe;jyhYk;> 
 ghohd ngz; khia jd;dpw; rpf;Fk; 
  ghq;fhd tpufj;jhy; Kaw;rpahYk; 
 jhohd gz;lq;fs; rikj;Jj; jpd;dy; 
  jhf;FNk fug;ghd; jd; rhay; jhNd 
 
 rhayha;j; jdf;Fj; jhd; %j;j ngz;izj; 
  jhtpNdhh; jho;r;rpahQ;rhjp jd;dpy;  
 fhayha;f; fye;Jz;Nlhh; fyfk; nra;Njhh; 
  fw;Gila kq;ifaiuf; fUjpNdhh;fs;  
 thayha; tho; kuj;ij ntl;bNdhh;fs; 
  kUj;Jth;fs; tz;zhh; ehtpjh;fs; $ypf; 
 $ayha;f; nfhlh Njhh;fs; FUepe;jpj;j 
  nfhLk;ghtp fug;ghdpw; Fwpf; nfhs;thNu”  
- A+fp itj;jpa rpe;jhkzp  
(fug;ghd; Nuhf epjhdk;) 
 Excessive intake of fish, meat, cereals like ragi, maize, rhizomes.  
 Excessive sexual indulgence. 
 Anti social activities which ultimately end in psychic 
disturbances leading to Karappan.   
 ‘ngUFQ; Nrhs kpWq;Fk; ngUq;fk;G 
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  tuF fhUld; thioapd; fhNahL 
 ciunfhs; ghfy; nfspw;W kPd; cz;bby; 
  tphpt jha;f;fug; ghDkp Fe;jNj” 
      -  rpj;j kUj;Jtk;  rpwg;G 
  
 This verse given above specifies the food items consumption of 
which can produce or aggravate karappan that is, bitter gourd, 
ragi, maize, unriped banana, fish items. 
 
 ‘rq;ifapy; tp\ fug;ghd; tUkhNwJ 
  rhuKld; fpUkp tpOe;jd;ikNaJ 
 cl;bzNk mjpfk; tUkpe;jphpa Nghfj;jh 
  YoWJUfp aj;jpapNyNtT nfhz;L 
 el;lzkha; nte;j njhU kr;ir jd;dpy; 
  ehl;lkpl;l fpUkpaJaZFk; NghJ 
 kl;LlNd fpUkpnay;yhk; gwe;jq;Nfwp 
  tifAlNd khq;fp\j;ijj; Jisj;J NkTk;” 
 ‘jpl;lKld; tpl fug;ghd; gwe;J NkNy 
  jpdTlNd guguj;Jr; nrhwpAz;lhNk 
 gay;nkhopapu; Njfj;jpy; fpUkpjhNd 
gue;JVtp Fl;lk;Nghy; Gs;spfhZk;  
kayJTq; fpUkpAe;jhd; ele;J Gf;fpy; 
  NkdpaJ rurnud ntbj;Jg; Gz;zhw; 
 fay; ngUFk; Foy; kltPh; nrhy;yf; Nfsph;  
  fufuj;Jr; nrhwp ngUFq; fug;ghd; jhNd”. 
 
      - FU ehb E}y; 
Excessive Sexual indulgence aggravates Azhal thathu which 
in turn affects the “ Kozhupphu” and “ Thasai”  of the seven udal 
kattugal. The micro-organisms enter through these affected thathus 
and cause Karappan. 
 
  
‘thjgpj;jq; fgkpit %d;wth; 
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  NwJ thy;ntsp thy;kpb ahtpdh; 
 Nfhij ahuba ghh;itah; thw;Fsph; 
  Ngj ephpit ahYd NgRNfs; 
 Ntff; fhw;wjpdh; gid nty;yj;jhy; 
  ghf kpf;fyhd; Nkjpg; ghnta;ayhy; 
 jhfkhdp tUf;f jprhh;jyhy; 
  Nghf thio tOjiy Ks;spf;fha; 
 fhAk; gy;yplj; jhw;Ruj; jhw;fspy; 
  vAk; tz;nlyp ahy;tUNk Jntsp 
 Fb ey;ywpthd vUtpdhh; 
  ad khd fug;ghd; tiffNs” 
     -  guuhr Nrfuk;; ....... rpuNuhf gFjp 
 Living in torrid climate and cold weather. 
 Excessive sexual indulgence. 
 Drinking contaminated water. 
 Airborne infection. 
 Excessive intake of palm jaggery and brinjals, plantain etc., 
 Poisonous bites  
                           are the predisposing factors. 
 
Neha; vz; (Classification) 
 
‘vz;gJ fug;ghd; jd;id apak;gpLkhW NfsPh; 
 ez;gpLk; thjk; gpj;jk; eyk;nfl;Lj;jhdk; tPq;Fk; 
Gz;gLk; fuq;fs; re;J Giye;Jly; fLj;J NehFk; 
 td;ikAld; ntbj;J R+iy tUtJ uzkPnjd;Nd” 
- mfj;jpah; uz E}y; 
 
As mentioned above karappan is classified into 80 types. 
 
 
 
 
 ‘ Mnkd;w fug;ghd;jhd; VOtpjkhFk; 
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  mlq;fhj thjj;jpd; fug;ghNdhL 
 fhnkd;w fz;lkhq; fug;ghdhFk; 
  fUfpa Njhh; twl;rpahq; fug;ghNdhL 
 Njnkd;w jpkph;thj fug;ghd; ehYk; 
  rpurpdpNy ngUq; fghyf; fug;ghd; 
 Nfhnkd;w gpj;jkhq; fug;ghNdhL 
  nghpa Nrl;Lkf; fug;ghd; ngah;jhNd” 
       - A+fp itj;jpa rpe;jhkzp 
As per the verse of yugi given above, karappan is classified in to seven types.  
1. thj  fug;ghd; ( vatha karappan) 
2. gpj;j fug;ghd; (pitha karappan) 
3. fg fug;ghd; (kaba karappan) 
4. jpkph;thj fug;ghd; (Thimirvatha karappan) 
5. fz;l fug;ghd; (kanda karappan) 
6. fghyf; fug;ghd; (kabala karappan ) 
7. twl;rp fug;ghd; (Varatchi karappan) 
 
            “nrg;Gthjf;fug;gd; Nrh;tul;rpf;fug;gd;  
ntg;GWk;ngUq;fug;gd; tpuw;wpkph;thjnkd;Dk; 
fg;GWfug;gNdhL fghyj;jpw;Nrh;fug;gd; 
jg;gWtp\ghfj;jpw; rhh;e;jpLq;fug;gdhNk. 
 
 
fug;GWGilfug;gd; fue;Jnfz;ilf;fug;gd; 
Jug;GWnrhwpfug;gd; J}q;fpLfug;ghNdhL 
epug;gptPq;Ff;fug;gd; ePz;bLntbf;fug;gd; 
mhpg;GWfug;ghNdhL mlh;fhzhf;fbf;fug;gd; 
 
fbj;jpLnrq;fug;gd; fUJ%yf;fug;gd; 
mLj;jRFzpfug;gd; mow;Wnfhs;spf;fug;gd; 
Jbj;jnfhg;Gsf;fug;gd; Njhd;Wfz;lf;fug;gd; 
neLj;jfw;fug;gNdhL ePs;nghj;jpf;fug;ghdhNk 
 
MFq;fhjpw;fug;g dhkpUgj;J %d;wpy; 
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thFWFzq;fNshL kUtpLkUe;JQ;rpq;ifr; 
NrfuhhpaNfhdhd nrfuhrNrfud;wd; 
XifNrh;e;jpLtjw;fh Ayfpdh;f;Fiuj;jjhNk. 
- nrfuhrNrfu itj;jpak; 
1. thj  fug;ghd;  
2. twl;rp fug;ghd; 
3. ngUq; fug;ghd; 
4. jpkph;thj fug;ghd; 
5. fghyf; fug;ghd; 
6. tp\ghf fug;ghd; 
7. Gil fug;ghd; 
8. nfz;ilf; fug;ghd; 
9. nrhwp fug;ghd; 
10. J}q;F fug;ghd; 
11. tPq;Ff; fug;ghd; 
12. ntb fug;ghd; 
13. mhp fug;ghd; 
14. fhzhf;fb fug;ghd; 
15. nrq; fug;ghd; 
16. %y fug;ghd; 
17. mRFzp fug;ghd; 
18. nfhs;sp fug;ghd; 
19. nfhg;Gs fug;ghd; 
20. fz;l fug;ghd; 
21. fw;  fug;ghd; 
22. nghjp fug;ghd; 
23. fhjpw; fug;ghd; 
 
fug;ghd; Nehapd; nghJf;FwpFzq;fs; 
 (General Signs and Symptoms)  
 
 "±ñÀÐ ¸ÃôÀ¡ý ¾ý¨dÂ¢ÂõÀ¢Î Á¡Ú §¸Ç¢÷ 
  ¿ñÀ¢Îõ Å¡¾õ À¢ò¾õ ¿Äõ¦¸ðÎò ¾¡Éõ Å£íÌõ 
 ÒñÀÎí ¸ÃôÀ¡ý ºóÐ Ò¨ÄóJ¼ø ¸ÎòÐ §¿¡Ìõ 
  Åý¨ÁÔ¼ý ¦ÅÊòÐî Ý¨Ä ÅÕÅÐ Ã½Á£¦¾ý§É" 
 "¯¨ÉïÍ§Á ÅÂ¢Ú¾¡ý º£¾í¸¡Ïõ 
  ¯‰½Á¡ö ãò¾¢Ãó¾¡ ÓÕí¸¢ Å£Øõ 
 «¨ÉïÍ§Á Âí¸¦ÁøÄ¡õ ¦º¡Ã¢Ôñ¼¡õ 
  «ÆÄ¡¸ ¦ÅÐõÀÄ¡öì ¸¡ì¸¸¡§Ä¡Ôõ  
  
 
 
Ò¨¸ïº§ÁÉ¢ Ä¢í¸ò¾¢ü Òñ§À¡Ö Õì¸¢ô 
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  ¦À¡Êô¦À¡ÊÂ¡ö Íñ½¡õÒì ¸ü§À¡ø Å£Øõ 
 ¸¨ÇïÍ§Á ¿£§Ã¡Î ÁÄÓQ;º¢ìÌõ 
  ¸º¢Ô§Á ¸ÃôÀ¡É¡õ" 
      - «¸ò¾¢Â÷ Å¢Ã½áø 
 
 Swelling all over the body.  
 Pain in the joints of the body. 
 Body temperature rises. 
 Abdominal discomfort with dysentry and burning    
                 micturition. 
 Appearances of papules, vesicles which burst leads to  
ulcer formation. 
 Oozing  from the lesion. 
 Itching all over the body. 
 Scanty micturation and Constipation. 
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thj fug;ghd; 
                          nghJf;FwpFzq;fs; 
 
‘clk;ngyhk; ntJk;gpnehe;J cise;Jfhy;re;Jiff 
splq;fspw;Rue;JtPq;fp apUe;Jgpd;Dthjpahfp 
Klq;fpNatuz;LNjhd;wp Kw;wpNantbj;Jg;Gz;zhk; 
,lq;nfhlhf;fug;gd;thj Fzkpnjd;wpak;gyhNk” 
 
‘re;Jjhs;nkhopnghUj;Jj; jhdq;fSise;JtPq;fp 
te;Jjhd;Gz;Nghw;fhak; tUe;jjpNaapUe;Jthb 
nehe;Jjhd;fdj;Jtw;wp NehTld;nrhwpAz;lhFk; 
,e;jNeha;jhDk;thj fug;gndd;wpak;gyhNk.” 
 
‘,Ue;njOe;jpUf;Fk;NghJ kpaw;Wq;fhy;fuq;fs;re;J 
tUe;jplj;jpkph;j;JtPq;fp tuz;bby;ntbj;Jg;Gz;zhk;  
jpUe;jpatq;fe;jhDk; nrakwg;nghUKkhfpy; 
tUe;Jkpf;Fzq;fs;fz;lhy; thjkhq;fug;gdhNk.” 
 
‘nehe;Jfd;wpajyj;jpy; NehTilGz;fs;jd;dpy; 
te;Jty;yhAjq;fs; tYTwj;ijj;jlj;jpy; 
re;Jjhs;nkhopnghUj;Jj; jhdq;fsjpNyahfpy; 
te;Jjhd;njhLf;Fnka;apy; thjkhq;fug;gdhNk.” 
 
‘fz;Ze;J}q;fpeLTe;jp fdj;Jr;Rue;JntJk;GKly;  
ez;Ze;JilAq;fdjpkpuha; iee;NjjiyAq; fpWfpWf;Fk; 
kz;zpw;gpwe;Njhh; jq;fsplk; te;NjtUe;jkaf;fpLfpy; 
vz;zpthjfug;gndd ,JTk; Ngryhnkd;whh;” 
 
‘tPq;Fq;Fj;Jk;kpfTisAk; tplhkw;wpkph;j;JtPq;fpepw;Fk;  
Vq;fg;Gz;zpw;ryk; tpOj ypJTe;jpdT nrhwpTnra;Ak; 
ePq;fpr; nrt;NtjPuhJ neLehl;gl;Nl krfpepw;Fk; 
Njq;fr;Rl;Lg;Gifj;Jtplj; jPUk;thjfug;gdpNj. 
- nrfuhrNrfu itj;jpak; 
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 The body temperature rises.  
 The lesions start as dry vesicles and later become exudative in 
nature leading to ulcer formation with secondary infection. 
 The lesions are highly Itchy in nature. 
 Pain and swelling in the affected areas of flexures of upper 
and lower limbs (like wrist Knee, ankle joints, etc.,). 
 Difficultly in walking due to swelling in the joints. 
 In severe cases extreme drowsiness, oedema of lower 
abdomen.  
 The lesions show recurrence.     
 
 
 " ¦¸¡ûÇ§Å ¯¼õ¦ÀøÄ¡õ ¦ÅÐõÀ¡ö ¦¿¡óÐ 
  Ì¨¼óÐ§Á Á¢¸î RÃóÐ Å£ì¸Á¡Ìõ 
 Å¢ûÇ§Å §¾¸¦ÁøÄ¡õ Òñ§À¡ø ¦¿¡óÐ 
  ¦ÅÊòÐ§Á Òñ½¡Ìõ Å¢Ãø¸û ºóÐ 
 ÓûÇ§Å Ó¼í¸¢§Â ¿ÃõÒ ¸¡Ïõ 
  ¦Á¡Æ¢¸û Àì¸Á¢ì¸ þ¼Á¢¸ ¯Ä÷óÐ 
 ÁûÇ§Å NkdpaJ tuz;L fhZk; 
thjkhq; ¸ÃôÀ¡ýÈý Åd;¨Á¾¡§É" 
     - ä¸¢ÓÉ¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ 
 That is, 
 
 Excessive body heat 
 Pain and swelling all over the body 
 Appearances of vesicles, exudates  
 Formation of ulcers 
 Difficultly to use affected limbs due to pain and  
swelling 
 Dryness of the body 
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Prognosis of Karappan (º¡ò¾¢Âõ - «º¡ò¾¢Âõ) 
  
"ã÷ì¸Á¡õ º¡ò¾¢Âò¨¾ ¦Á¡Æ¢Âì §¸Ç¡ö 
  ¦Á¡Æ¢¸¢ýÈ Å¡¾ ¸ÃôÀ¡ý Èý§É¡Î 
 °÷ì¸Á¡õ À¢ò¾ ¸ÃôÀ¡ÛÁ¡ Ìõ 
  ¯Â÷¸¢ýÈ ÅÈðº¢Â¡í ¸À¡Äì ¸ÃôÀ¡ý 
 ¾÷ì¸Á¡ apÐ¿¡Öï º¡ò¾¢ÂÁ¡õ  
  ¾Ùì¸¡É ¾¢Á¢÷Å¡¾ì ¸ÃôÀ¡ý ¸ñ¼õ 
 ¿£÷ì¸Á¡ï §ºðÀ ¸ÃôÀ¡ýÈý §É¡Î 
  ¦ºôÀ¢Â§¾¡÷ þÐ ãýÚõ «º¡ò¾¢ÂÁ¡§Á" 
     - ä¸¢ ¨Åò¾¢Â º¢ó¾¡Á½¢
º¡ò¾¢Âõ(curable) 
1. Å¡¾ ¸ÃôÀ¡ý(vatha karappan) 
2. À¢ò¾ ¸ÃôÀ¡ý(pitha karappan) 
3. ÅÈðº¢ ¸ÃôÀ¡ý(varatchi karappan) 
4. ¸À¡Ä ¸ÃôÀ¡ý(kabala karappan)  
 
 
«º¡ò¾¢Âõ (incurable) 
1.¾¢Á¢÷Å¡¾ ¸ÃôÀ¡ý(Thimirvatha karappan) 
2.¸ñ¼ ¸ÃôÀ¡ý(kanda karappan) 
3.§ºòÐÁ ¸ÃôÀ¡ý(setthuma karappan) 
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gj;jpak; kw;Wk; czT Kiw 
‘gj;jpaj;ij NehiaaD ghdj;ij yq;fzj;ijg; 
gj;jpaj;ij Kd;kUtd; gz;zypw;nfhs; - gj;jpaj;ij  
Vfkh ahHj;jhY Nkwhr; nrtptopNghNdha; 
Vfkh ahHj;jhY nka;” 
-Njud; akf ntz;gh 
 fug;ghd; Nehapid cz;lhf;ff;$ba kw;Wk; mjpfg;gLj;jf;$ba czT 
tiffis ePf;f Ntz;Lk;. mitahtd 
 
Nrhsk; - Sorghum Vulgare 
‘Nrhsnkdg; NghH gilj;j NrhWfspdhYk; clypy;  
kPshr; nrhwprpuq;F tpHj;jpahFk; ehSq; 
fug;ghDk; cz;lhk; fdkUe;Jk; ghohk; 
gug;gida fz;khNj! ghH” 
 
nfhs; - Dolichos Biflours 
‘Fly;thjq; Fd;kKz;lhq; nfhs;kUe;Njh ehrk; 
  mlNyW gpj;jkpf MFq; - fLfLj;j 
 thj ePNuw;wnkhL kd;DFspH fha;r;rYk;NghQ; 
  rhjp eWq; nfhs;Sf;Fj; jhd;” 
 
ghfy; - Memoridica Charantia 
 ‘kUe;Jfspd; ew;Fzj;ij khw;Wk; m/jd;Nwh 
  jpUe;jtyp thjj;ijr; NrHf;Fk; - nghUe;Jgpj;jq; 
 $l;Lkjp gj;jpaj;ijr; nfhz;bUf;Fk; td;fug;ghd; 
  fhl;Lf; nfhk;Gg;; ghfw; fha;” 
 gpj;jnkhL thjg; ngUf;if kpf cz;lhf;Fe; 
  je;J fug;ghidj; jUtpf;Fk; - gw;wp uj 
 jhu ghlhze; jik Kwpf;Fe;j jg;ghJ 
  fhuty;ypahk; ghfw;fha; 
rpy kPd; tiffisAk; ePf;f Ntz;Lk;. 
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 ‘kapwp Fwit tuhy; Njsp 
  kw;Wk; Fwit eha;f; nfspW 
 mapiu rd;id gj;jpakhk; 
  Mfh kPd;fs; ,dpf;NfSk; 
 caUk; this ,why; $dp 
  Xq;F nfspW tpyhq;F nfz;il 
 faNyhbitfs; Mfhthq; 
  fhuhH FoNy fz;LiuNa’ 
 
nfha;ah - Psidium Guajava 
 jphpNjh\k; nrd;dpj; jpUg;g kNuhrp 
  ngUke;jk; the;jp nghUky;; - fug;ghDk; 
 nka;aha; guT kyk; nkj;jtUk; NghfKz;lhq; 
  nfha;ah goj;jpdhw; $W 
 
Kl;il - Gallus Domesticus 
 thjgpj;jQ; NrHg;gpf;Fk; td;Nwhlk; Gz;zhf;Fe; 
  jhJit nkj;j jiog;gpf;F - NkhJ 
 fgj;ij alf;Fq; fug;ghDz;lhf;F 
  kpgj;ijAWq; NfhopKl;il nad; 
cg;G 
 nrhl;il eiu jpiu Jl;lePH gk;G Gz; 
  kl;lw;w ehtwl;rp thjuj;jk; - Fl;lKz;lhk; 
 Njftd;ik NjAk; jpUNtjpdk; mjpf 
  khfTg;ig Az;lhff; fwp. 
 
fj;jhp - Solanum Melogena 
 gz;L khz;l fpue;jpiag; ghjpf;Fk; 
  cz;l iff;Fe; jpdit Az;lhf;fptpLk; 
 ez;L fl;Lq; Fuq;nfd ehSkhq; 
  fz;L tpl;lJ fj;jhpf; fhaNj 
 
 
khk;gok; - Magnifera indica 
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 jpd;whw; wpdntLf;Fe; jPgdk; Nghk; neQ;nrhpthk; 
  md;Nw tpopNeha; mlUq;fhz; - Ed;wpkpf 
 thjfug;ghDk; td; fpue;jpAk; ngUFQ; 
  #jf; fdpapd; Rfk;. 
 
Gsp - Tamarindus Indica 
Gj;jpAk; ke;jkhFk; nghUkpNa clY%Jk; 
 gj;jpak; jtWk; re;jp ghjkhk; Ruq;fs; tPWQ; 
rHj;jpAk; gpj;Je; jPUk; jDntDk; thj NkWk;  
kj;jpae;j jhJG\;b tUe;jpiu eiu Gspf;Nf 
,tw;Wld; fk;G> tuF. fhuhprp> thiof;fha;> jbaq;fha; ,tw;iwAk;  
ePf;f Ntz;Lk;. 
- gjhh;j;j Fz rpe;jhkzp 
 
 vspjpy; rPuzpf;Fk; czT tiffis vLj;Jf; nfhs;sy; eyk;. 
 kuf;fwp czT> ghy; kw;Wk; ghy; nghUs;fs;> rj;Js;s  czTfs; 
cl;nfhs;syhk;. 
 krhiy nghUs;fs; (Spicy Foods) kzg; nghUl;fs;> Nghijg; nghUl;fs;> 
fhug; nghUl;fs; ePf;f Ntz;Lk;. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MODERN ASPECTS 
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ECZEMA 
Definition 
Dermatitis and eczema is non contagious inflammation of the 
skin characterized by erythema, scaling, oedema, vesiculation and 
oozing. 
Eczema has been used as a descriptive term since the sixth 
century. 
Eczema is a Greek word (Ec-means “out”, zeo-means “boil”). 
The whole word implies “boil out”. 
Eczema is a specific type of allergic cutaneous manifestation 
of antigen-antibody reaction. 
Aetiology 
Basically, two factors cause dermatitis and eczema.  
Firstly, all allergic or sensitive skin. Secondly, exposure to an 
irritant.The dermatologist Darier has correctly said that, 
“There is no eczema but an eczematous patient”  
The general predisposing causes are  
Age 
Eczema sometimes occurs in infancy, at puberty and at the 
time of menopause. 
Genetic & familial predisposition 
There is usually a personal or family history of allergy, viz 
asthma, eczema and hay fever. 
General debility 
By lowering resistance of the individual predisposes to 
eczema. 
Climate 
Climate extremes like heat and severe cold. 
 
Psychological stress 
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Local factors 
Xeroderma or ichthyosis, a greasy skin hyperhidrosis, 
varicose veins. Direct contact with pet and domestic animals 
(especially their saliva or fur) and indirect contact with animal 
dander. 
Rough, scracy, tight clothing, especially clothes made of wool 
(or) stiff fabrics. 
The frequent use of soaps and cleaning products that tend to 
give lack of normal shiny of the skin. 
 
FOOD AS ALLERGENS 
a) Animal sources 
Cow’s milk – Casein and β lactoglobulin are known to be the 
major allergen. Egg white is the allergising factor. 
Any species of fish can responsible for allergic reactions 
Meats of all kinds –It has been observed that in cases of 
hypersensitiveness to the meat of a certain animal, the liver, 
pancreas, kidney and brain. 
 
b) Plant sources 
Wheat flour – allergic reaction due to wheat gluten 
Some workers in glue factories using soya flour as an 
ingredient of glue, develop severe allergic symptoms. 
Peas, beans and lentils have been reported to produce allergic 
reactions in some individuals. 
Consumption of edible mushrooms sometimes may cause 
allergic reactions. 
Fats and oils have been found to produce allergic symptoms 
in some individuals. 
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The vegetables which have been found to produce allergic 
reactions in some individuals are carrot, spinach, cabbage, onion, 
garlic, sweet potato, cauliflower and pumpkin. 
Among the fruits, strawberries, bananas, oranges, grapes and 
apples are the principal offenders. 
Occasionally allergic reactions can occur due to consumption 
of pears, cherries, plums, gooseberries. 
Citrus fruits and tomatoes may cause atopic allergy. 
 
Beverages 
Allergic actions are due to traces of foreign substances derived 
from food materials employed in the preparations or clarifying the 
beverage, such as 
¾ Barely malt and yeast in beer 
¾ Rye corn and wheat in whisky 
¾ Fish, glue, egg white or yeast in cheap white 
wine and champagne 
Food contaminants as allergens 
For example preservations, insecticides and insect excreta or 
fragments may act as allergens. 
Nor dihydroguairetic acid (NDGTA) is an antioxident used in 
food facts. 
 - Dietetics 4th edition 
             B. Srilakshmi 
Cosmetics 
Common ingredients in cosmetics such as perfumes, face 
creams, deodarents, hair dye, shampoos, parabens, benzocaine, 
lanolin, thimersol, etc. 
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Clothing 
 Rubber chappals, spectacle, resins, frames, furs, nylon, 
synthetic dyes. Most buttons are formaldehyde resins, epoxy resins 
are all common sensitizers. 
Medicaments 
This include Sulphonamides, Penicillin, Streptomycin, 
Cocaine, Tincture, Benzoin, Detol, Phenergon cream & Sticking 
plaster etc. 
INDUSTRIAL AND OCCUPATIONAL AGENTS 
Occupational 
Agriculturists   - Plants, weeds, fertilizers 
Automobile   - Oil, petrol, solvent, grease, paints 
Building workers  - Cement, lime, paints, insecticides,   
Chemical and  
Pharmaceutical industries -  Dyes, Chemicals, explosives,  
solvents, disinfectants, detergents 
Coal miners   - Mechanical injuries  
Dentists    - Cocaine and its derivatives 
Engineering  industries - Cutting oils, solvents 
Housewives   - Soaps, detergents, vegetables,  
fruits, nickel , polishes, artificial  
flavours 
Nurses and Doctors  - Iodine,streptomycin, chlorpromazine,  
tincture , benzonin  
Photographers   - Hardeners, solvents, glass,  
cellulose esters 
Rubber workers   - Additives like TMT, MBT, dyes,  
glues, oils 
Tannery workers  - Chromate, formaldehyde, arsenic,  
alkalies, acids. 
Textile workers   - Formaldehyde, solvents, dyes 
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Ten common allergens come across in practice 
1. Paraphenylene diamine 
2. Nickel sulpahte 
3. Pottasium dichromate 
4. Parthenium hysterophorus 
5. Nitrofurazone ointment 
6. Neomycin sulphate 
7. Formaldehyde 
8. Turpentine 
9. Garlic 
10. Epoxyresin 
 
EXACERBATING FACTORS 
 Irritants   - Physical, chemical or electrical  
 Sensitizers  - Plants, clothing, cosmetics,  
medicaments, infection, diet and  
focal sepsis. 
 External infections  -  Streptococci, Staphylococci,  
     fungus. 
 Diathesis    -  Allergic, Xerodermic,  
     hyperhidrotic or  seborrhoeic 
 Drugs     - State of local or general nutrition 
 Climate    -   Temperature and humidity 
 Mental and emotional conflicts. 
 Internal septic focus shedding toxins or causing 
bacteraemia 
 Scratching, Chemical trauma, Climate, Stress and Strains 
keep the process going with the result that eczema 
becomes chronic 
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  It is still controversial whether the endogenous factors like 
diet, emotional strain and stress, focal sepsis, state of digestion, 
nutrition are more important than exogenous factors like infection, 
irritants and sensitizers (or)  vice  versa. 
  
In practice mixed eczemas are much more common than pure 
entities. History and clinical observation are very important in 
establishing the exact etiological diagnosis. 
Immunology  
Immunology is a science which deals with the body’s response 
to antigenic challenge. 
This mechanisms are involved in the protection of the body 
against infectious agents but periodically they can also cause 
damage. 
Sensitization develops when a different clone of T-lymphocytes 
is activated. The sensitized T-lymphocytes yield two sub 
populations of lymphocytes. 
1. Memory cells that are responsible for the persistence of 
contact allergy. 
2. Effector cells that initiate the allergic response when 
appropriately challenged. 
 
PATHO PHYSIOLOGY 
Allergy & hypersensitivity 
 
Both terms are synonyms. 
The concept of hyper sensitivity was first introduced by 
Portier and Richet. 
The term allergy was first used by Von Pirquit (1874 - 1929) 
to denote changed reactivity of the body to outside chemicals. 
Changed reactivity in this context means  that the body 
behaves in a particular way when it is exposed to a chemical 
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substance known as ‘Allergen’ for this first time, but changes the 
nature of its reaction when it is exposed for the second and 
subsequent times. This change is due to proteins known as 
antibodies. 
The moment, the allergen IgE combination stimulates the 
mast cells which unload their chemical contents into the 
surrounding tissues. These chemicals (mediators of allergy)  cause 
the manifestations of allergy such as erythema, wheal  and flare 
reaction. Flare is due to dilatation of arterioles by local axon reflex 
and the liberation of vasodilator substances like histamine and its 
by products like serotonin, bradykinin, acetylcholine from the 
injured cells like mast cells and basophils etc., The manifestation of 
hypersensitivity may be immediate (or)  delayed  type. 
 
Cutaneous Allergy 
In the skin there are two important but different allergic 
reactions occur. 
 
Dermal reaction 
 Dermal reaction is commonly seen in urticaria.   
 The causuative antigen reaches the skin through ingestion, 
inhalation or injection of protein substances and the 
reacting antibodies, circulate in the serum. 
 Allergic reaction takes place in the dermis 
 Intra dermal tests (scratch) shows reactivity 
 
Epidermal reaction 
 It is seen in allergic dermatitis or eczema. 
 The causative substance reach the skin by contact, Intra 
dermal allergic tests are negative. 
 But patch test shows reactivity 
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 Allergen + Epidermal protein – Antigen formation (probably 
in lymph glands) 
 Circulation  - Fixed in epidermal cells on next occasion 
 Allergen + Antibodies – Eczematous reaction (In epidermis) 
 A severe local reaction may result in auto-intoxication & 
dissemination of eczematous reaction to distant parts. 
 
Status Eczematicus 
It is believed that in case of severe allergic states, a state may 
develop when the patient becomes hypersensitive to even unrelated 
substances resulting in status eczematicus comparable to status 
asthmaticus in practice of internal medicine. 
 
Reaction time 
It is the time taken by a sensitized individual to manifest a 
clinical reaction following contact with a known sensitizer. 
It is usually 12-24 hours but may vary from one hour to 120 
hours. 
Dissemination reaction 
It is a fleeting erythematous macular reaction involving the 
face and flexures, caused by the escape of  lymphokines in the 
circulation resulting in vasodilatation at distant site.  
 
Cause of recurrence 
Flare reaction is reactivation of a previously healed site of  a 
contact dermatitis or a positive patch test reaction following 
renewed challenge or exposure to the same allergent at another 
site. This is because of persistence of sinsitised lymphocytes at the 
site of earlier reaction, which react to minute amouts of antigen  
sometimes escape in the circulation form the new site and find its 
way to the old site 
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Further it must be realised that Dermal or epidermal 
sensitization affects the entire integument and this sensitization 
once acquired is life – long. According to some, a degree of bloating 
in reactivity may be seen with the passage of time 
 
CLINICAL FEATURES  
Eczema is a specific type of allergic subcutaneous 
manifestation of antigen antibody reaction. It is characterized by 
superficial inflammatory oedema of the epidermis associated with 
vesicle formation. Itching varies from mild to severe paroxysms 
which may even interfere with work and sleep. The natural history 
of eczema is represented as follows 
 
 
HISTORY OF ECZEMA 
 
Erythema 
      
 Papules with oedema 
      
Vesicels      
 
        Weeping, crusting, pustules  Lichenification 
          
  Scaling 
    
       Healthy skin without scars 
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CLASSIFICATION 
 
There are two groups of eczema. 
 Exogenous Endogenous 
Irritant Atopic 
Allergic Seborrhoeic 
Photodermatitis Discoid 
 Asteatotic 
 Gravitational 
 Neurodermatitis 
 Infectious  eczymatoid   
Exogenous Eczema 
Irritant eczema 
Detergents, alkalies, acids, solvents and abrasive dusts are 
common causes. Irritant eczema accounts for the majority of 
industrial cases and work loss. 
The elderly, those with fair and dry skin and those with an 
atopic background are especially vulnerable. Napkin eczema in 
babies is common and due to irritant ammonical urine and faeces. 
Strong irritants elicit an acute reaction at the site of contact 
where as weak irritants most often cause chronic eczema, especially 
of the hands after prolonged exposure. 
 
Allergic contact dermatitis 
Definition 
Allergic contact dermatitis is an eczematous rash that 
develops after contact with an agent due to delayed cellular 
hypersensitivity. 
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Aetiology (Allergens) 
They are classified into two groups 
 Non proteins - Dyes, oils, resins, coal for derivates, 
rubber, cosmetics and chemicals. 
 Proteins - Bacterial products, fungi and parasites are 
included in this group. 
 
Persons may be exposed to allergens for years before finally 
developing hypersensitivity. The sensitized area although usually 
generalized may be strictly localized. 
Eg: Eczema of the ear lobes wrists and back due to contact 
with nickel in costume jewellery. 
 
 
Some common allergens 
Nickel Jewellery, Jean stuels, bra clips 
Dichromate Cement leather, matches 
Rubber chemicals Clothing, shoes, tyres 
Colophony Sticking plaster, collodion 
Paraphenylene diamine Hair dye, clothing 
Balsam of peru Perfumes, citrus fruits 
Neomycin, benzocaine Topical applications 
Parabens Preservative in cosmetics and creams 
Wool alcohols Lanolin, Cosmetics, creams 
Epoxy resin Resin adhesives 
 
Photo dermatitis 
Photo dermatitis means photo sensitization of the skin after 
contact with plants which have either photo toxic or photo allergic 
action. 
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Dermatitis in this condition, is confined to the exposed parts 
of the body viz, face, neck, “v” of the chest, hands and external 
surfaces of the fore arms and dorsum of foot and the adjoining 
parts of legs. 
The common causes of photo dermatitis are,  
 Drugs like sulphonamides, chlorpromazine, Promethazine, 
declamycin, terramycin, chlorthiazide, diuretic, different 
hypotensive and anti diabetic drugs. 
 Foods like figs and buck wheat. 
 External application of bithionol etc., 
 Plants and their products like parsnips, cow parsnips 
meadow grass mustards, lime oil, psoralea, bergmot oil 
etc., 
 
Endogenous eczema 
 There is no evidence of external irritants or allergens in 
endogenous eczema part of the body becomes sensitized to internal 
body products, toxins from focal sepsis, metabolites that are 
products of digestion (or) elements of diet and drugs with or without 
familial predisposition to this list should be added psychosomatic 
influences. 
Atopic eczema 
It is also called asthmatic eczema syndrome  
Atophy (out of - place - ness) is a genetic predisposition to 
form excessive IgE which leads to a generalised and prolonged 
hypersensitivity to common environmental antigens. 
Atopic individuals manifest one or more of a group of diseases 
that includes asthma, hay fever, urticaria and this distinctive form 
of eczema. 
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Aetiology 
The inheritance of atopic eczema is controversial. The disorder 
is concordant in 86% of monozygotic twins but in only 21% of 
dizygotes. 
Atopic diseases show maternal imprinting i.e., they are 
inherited more often from the mother than from the father. 
 
Distribution and character of rash 
Infancy 
The eczema is often acute and involves the face & trunk. 
The napkin area is frequently spared. 
Childhood 
The rash, settles on the back of the knees, front of the elbows, 
wrists & ankles. 
 
 
Adults 
The face and trunk are once more involved lichenification is 
common. 
 
Diagnostic criteria 
♣ Itchy skin and at least three of the following. 
♣ History of itch in skin creases (or cheeks if < 4 years) 
♣ History of asthma / hay fever (or in a first – degree relative if   
< 4 years) 
♣ Dry skin (Xeroderma) 
♣ Visible flexural eczema (cheeks, forehead, outer limbs if < 4 
years) 
♣ Onset in first 2 years of life 
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Seborrhoeic Eczema 
 This condition which is characterised by a red scaly rash 
classically affects the scalp (dandruff) central face, nasolabial folds, 
eyebrows and central chest. 
It is due to pityrosporum ovale infection of the skin. 
In its milder forms it is the same as dandruff where as when 
severe it may resemble psoriasis. 
Sebum may be permissive for the development of the rash. 
Seborrhoeic eczema is a feature of AIDS and can be very 
severe in this condition. 
 
Discoid eczema 
Synonym : Nummular eczema 
This is a common form of eczema recognised by discrete coin-
shaped lesions of eczema seen on the limbs of young men 
associated with alcohol excess, and of elderly men. 
It can occur in children with atopic eczema and tends to be 
more stubborn to treat.  
Aetiology 
• Psychogenic stresses 
• Focal sepsis 
• Food allergies 
• Alcohol 
• Debility and drugs 
A dry skin and cold weather may be associated with it. 
Sometimes it may be associated dyshidrosis of palms and 
soles, and discoid patches of keratoderma. 
Asteatotic eczema 
This is frequently seen in the hospitalized elderly especially 
when the skin is dry, low humidity caused by central heating over 
washing and diuretics are contributory factors. 
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Gravitational (stasis) eczema 
Persistent inflammation of the skin of the lower legs 
commonly associated with venous in competency. 
The eruption is usually localized to the ankle, where oedema, 
erythema, mild scaling and brownish discoloration occur. 
Secondary bacterial infection and eventual ulceration may occur. 
The cause is mainly due to perivascular fibrin deposition and 
abnormal small – vessel vaso constrictive reflexes. 
Neuro dermatitis 
Synonym : Lichen simplex chronicus 
Affecting more commonly neurotic people. 
Definition 
This condition may be defined as the lichenification process 
resulting from chronic scratching and rubbing of the skin under 
stress and anxiety.  
Clinical features 
The skin become thickened, infiltrated and pigmented. The 
criss cross markings become more prominent. Margins are irregular 
& usually well defined. 
 
Common sites 
The nape of the neck, arms, ano-genital area, back of knees, 
legs and ankles. 
 
Pompholyx (dyshidrotic eczema) 
Recurrent vesicles and bullae occur on the palms, palmar 
surface of the fingers and soles. 
It is most common in adult life (20-40 yrs)  
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Provoking factors 
• Heat 
• Stress   
• Nickel ingestion 
But is often idiopathic. 
Infectious eczematoid dermatitis 
Synonym: Infective eczema 
This results from sensitization to certain organisms like 
streptococci, staphylococci, dermatophytes and yeast organisms. 
Clinical features 
Characterised by their slow development no vesiculation is 
usually evident a crust is formed instead. The patch or patches are 
sharply defined and there is no erythematous halo. 
Sites: Body folds, hair follicles. 
 
Sub divisions 
1) Post traumatic infective eczema 
It starts with a crack in the integrity of the skin brought on by 
an injury, a blister an insect bite or exposure to a cold wind etc. 
Eczematization secondary to acute tinea, particularly tinea 
pedis is frequently seen. It starts from digital spaces and spreads to 
the dorsum of the foot or the soles. 
 
2) Follicular infective eczema 
It involves hairy region like the scalp, beard and legs. It starts 
usually with pityriasis capitis which gets complicated by one (or) 
several itchy patches of oozing, pits and crusting. The eczema 
spread to fore head, retro auricular folds and cheeks. Streptococi, 
staphylococci and less so Pityrosporon organism are the causatives. 
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3) Flexural infective eczema 
The flexures are the sites of predilection.  It starts with a 
crack in the depth of the fold and two opposing surfaces are equally 
affected.  The inner part looks moist and red only at the periphery 
is crusting clearly evident. 
 
Infantile eczema 
This occurs in children between the ages of three months and 
two years.  It usually starts on the cheeks, spreading slowly to 
forehead, chin, scalp, arms, trunk, legs, buttocks and in the groins, 
napkin rash like dermatitis may develop. 
Etiology 
Dietetic allergies may play an important role in the causation 
 
Clinical features 
Characterized by erythema, vesicles, exudation and crusting 
pruritus is a prominent symptom, it comes in spasms. To start with 
the infants are usually plump. 
Types 
1. With high familial predisposition to an allergic disease – 
The atopic   variety 
2. Without familial predisposition – Simple variety 
 
Investigation of Eczema 
Patch test 
Patch tests detect type IV (delayed or cell-mediated ) 
hypersensitivity. 
It is common practice for a battery of around 20 common 
antigens, including common sensitizers such as nickel, rubber and 
fragrance mix to be applied to the skin of the back under 
aluminium discs for 48 hours. 
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The sites are then examined for a positive reaction 24 hours 
later and possibly again a further 24 hours later. 
The positive test is revealed by the development of an 
eczematous patch with erythema swelling and vesicles at the site of 
application. 
  
Patch test reaction is graded in the following degress 
  + - Only redness 
  ++ - Marked redness and swelling 
  +++ - Marked redness , swelling and papules 
  ++++ - redness, oedema and vesicles 
Specific IgE 
Specific IgE levels to antigens can be measured in serum by a 
specific radio allergic sorbent test (RAST) 
These are occasionally performed to support diagnosis of 
atopic eczema and to determine specific environmental allergens, 
eg. pet dander, horse hair, house dust mite, pollens and foods.   
 
 
Prick tests 
Prick tests are a way of detecting cutaneous type I (immediate) 
hypersensitivity to various antigens such as pollen, house dust, 
mite or dander. 
 
Bacterial and viral swabs for microscopy and culture 
These are useful tests in suspected secondary infection skin 
swabs for bacteriological assessment will invariably reveal the 
presence of bacteria.  In the case of recurrent impetigo in a child 
with atopic eczema, bacterial swabs should be taken from carrier 
sites (axillae and groin) from both the affected individual and house 
hold members. 
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Hints of diagnosis for all eczemas 
1. Nature of the lesions- size, shape, itching, number of 
papules, pustules, erythema etc., 
2. Distribution – sites of lesion. 
3. History of occupation. 
4. History of exposure to allergens – i.e. Chemicals, plants, 
soap, etc., 
5. Personal and family History of such diseases – e.g atopic or 
allergic eczemas. 
6. Climate – eg:  Dyshidrosis occurs at the change of seasons 
particularly in spring, summer. 
7. Patch tests ( allergy test) in allergic/ atopic eczemas. 
8. Biopsy in rare cases when the lesions do not respond to 
treatment. 
Prognosis of eczema 
Dermatitis and eczema are as rule curable conditions. Eczema 
are ineffective except when they are leave scars. The patient needs 
reassurance of these points. 
It must be remembered that epidermis is an ectodermal 
structure and so takes time to heal.  Energetic treatment is to be 
strongly discouraged. 
Acute eczemas heal readily in about 1-4 weeks with 
treatment. 
Chronic eczemas in which anatomical and functional changes 
set in take time to disappear. 
Disseminated and generalized eczemas are not only slow to 
heal, but are accompanied by ill health. Infantile and atopic 
eczemas are trouble some and uncomfortable. 
The former lasts till the age of twenty five or even though life. 
Its course is marked by spontaneous remissions and exacerbations. 
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Psychogenic stresses climate extremes and poor health 
aggravate eczema. The cure of these conditions is retarded in 
tropical countries by heat, humidity and the prevalent unhygienic 
conditions. 
 
 
- Roxburgh’s common skin diseases – Ronald   
  Marks 
- Practice of Dermatology – Dr. P.N. Behl  
  (Ninth Edition). 
- www.skincarephysicians.com 
- www.medicinenet.com 
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 MATERIALS AND METHODS 
 
The clinical study on Vatha karappan was carried out in the 
inpatient ward of Ayothidoss Pandithar Hospital of National 
Institute of Siddha, Chennai – 47. 
Approach towards the patients was made according to the 
signs and symptoms of Vatha karappan as mentioned in siddha 
literature. 
Selection of cases 
For this clinilal study 30 cases were selected from both sexes 
of varying age groups.Out of 30 patients selected 19 were admitted 
in the in patient ward and treated, and 11patients were from o.p. 
department. 
Evaluation of clinical parameters 
During admission a detailed clinical history with details of 
family history, allergic history, aggravating factors, occupation, 
socio–economic status, dietary & personal habits and associated 
history such as bronchial asthma and hay fever was taken from the 
patients. The cardinal signs & symptoms like itching, erythema, 
vesicles, oozing, pain, oedema, crusting, scaling and ulcers were  
taken as criteria for the Vatha karappan cases. 
Diagnostic aspects of Siddha   
Separate individual case sheets were prepared on the basis of 
siddha methodology i.e. poriyal arithal, pulanal arithal, vinathal, 
envagai thervugal, ezhu udal kattugal, thinai, paruva kaalam, etc., . 
 
The clinical investigations 
The modern diagnostic  investigations such as  Blood tests for 
TC, DC, ESR, HB, sugar and urine analysis for sugar. 
After discharge, all the 19 patients were advised to attend out-
patient department for further follow up.  
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 Pharmacological analysis of the trial drug was conducted at 
the pharmacology department, A.J College of pharmacy,Chennai-
119. 
 
Management 
“Viresanathal vatham thazhum” ie, purgation lowers vatham 
and so the patients were advised to take Meganatha Kuligai 1-2 
Tablets with hot water (early morning in empty stomach) before 
starting treatment with trial drug. 
 
Trial Drugs 
1) Vathakarappan chooranam - 1-2 gm twice a day  (morning 
and evening) with palm Jaggary. 
s2) Amanakku ennai – Applied  externally over the affected      
areas. 
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OBSERVATION AND RESULTS 
 
Results were observed with respect to the following criteria:  
 
• Sex distribution 
• Age distribution 
• Kaalam distribution (life span) 
• Occupational status 
• Socio economical condition 
• Diet  
• Seasonal  
• Thinai  (land and place) 
• Gunam (characters) 
• Mode of onset 
• Aetiological  
• Clinical features 
• Associated history 
• Duration of the illness before treatment 
• Distribution of Uyir thathukkal 
• Ezhu (seven) udar kattugal  
• Envagai thervugal 
• Neerkuri and Neikuri  
• Results after treatment 
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SEX DISTRIBUTION 
 
Out of 30 patients selected for the clinical study 63% were 
males and 37% were females. 
 
Sl.No
. 
Sex No. of 
cases 
Percentag
e 
1. Male  19 63% 
2.        Femal
e 
11 37% 
 
 
 
 
Male 
63%
Female
37%
SEX DISTRIBUTION
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AGE DISTRIBUTION 
Out of 30 cases selected for clinical trial, 10 were above the 
age of 50. 
 
Sl.No. Age No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
<    20 
21-30 
31-40 
41-50 
51-60 
61-70 
71-80 
1 
2 
3 
8 
10 
4 
2 
3.3% 
6.6% 
10% 
26.6% 
33.3% 
13.3% 
6.6% 
 
 
 
 
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
<    20 21-30 31-40 41-50 51-60 61-70 71-80
AGE DISTRIBUTION
AGE 
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KAALAM DISTRIBUTION 
30 cases of different age groups were treated and 70% of them were 
in the pitha kaalam, 20%  in kapha kaalam and 10%  in vatha 
kaalam. 
 
Sl.No. Kaalam No. of 
cases 
Percentage 
1. 
2. 
3. 
Vatha Kaalam (0-33) 
Pitha Kaalam (34-66) 
Kapha Kaalam (67-100) 
3 
21 
6 
10% 
70% 
20% 
 
OCCUPATIONAL STATUS             
Occupation is closely associated with vatha karappan which is 
evident from the table given below: 
 Sl.No. Nature of work No.of.cases Percentage 
1. 
2. 
3. 
 
4. 
5. 
    
   6. 
Farmers 
Coolies 
Workers in chemical 
industries 
House Wives 
Employees of 
stressfuloccupations 
Others 
8 
4 
2 
 
5 
8 
 
3 
26.6% 
13.3% 
6.6% 
 
16.6% 
26.6% 
 
10% 
 
From the table above, it is learned that farmers and employees of 
stressful occupations are highly affected. 
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SOCIAL, ECONOMICAL CONDITIONS 
The incidence of the disease was found to be higher in lower 
economic groups 
 
Sl.No. Socio-economic status No. of cases Percentage 
1. 
2. 
3. 
Poor 
Middle 
Rich 
14 
13 
3 
46.6% 
43.3% 
10% 
 
DIET  
Cases were enquired of their dietary habits and it was noted 
that 96.6% cases were non-vegetarian and only 3.3% were 
vegetarian. 
 
Sl.No. Diet Habit No. of cases Percentage 
1. 
2. 
Vegetarian 
Non-vegetarian 
1 
29 
3.3% 
96.6% 
 
 
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
Vegetarian Mixed Diet
DIET REFERENCE
Percentage
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Paruva Kaalam(Season) 
Out of 30cases the highest incidence was during Koothir 
kaalam followed next by Munpani kaalam  
Sl.No. Paruva Kaalam No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
Kaar Kaalam 
Koothir Kaalam 
Munpani Kaalam 
Pinpani Kaalam 
Elavenil Kaalam 
Muthuvenil Kaalam 
- 
11 
9 
5 
5 
- 
- 
36.6% 
30% 
16.6% 
16.6% 
- 
 
THINAI (Land) 
100% of cases reported from the  Neithal  Thinai. 
 
GUNAM  
All the 30 cases were of  Rajo gunam. 
 
MODE OF ONSET 
Out of 30 cases  80% of cases were found to be chronic 
sufferers. 
Sl.No. 
Mode of 
Onset 
No. of 
cases 
Percentage 
1. 
 
2. 
Acute 
 
Chronic 
6 
 
24 
20% 
 
80% 
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AETIOLOGICAL FACTORS 
When the 30 cases taken for study were observed, occupation, 
stress and insect bite were the main causative factor for the 
disease. The incidents were as follows; 
 
Sl.No. Aetiology No. of cases Percentage 
1. 
2. 
3. 
 
 
Occupational status 
Stress induced 
Insect bite  
 
 
13 
12 
5 
 
43.3% 
40 % 
16.6 % 
 
 
 
 
 
 
 
 
 
  
0
5
10
15
20
25
30
35
40
45
Occupational
status
Stress induced Insect bite 
AETIOLOGICAL FACTORS
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CLINICAL FEATURES 
Sl.No. 
Clinical 
features 
No. of 
cases 
Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
Constipation 
Erythema 
Itching 
Vesicles 
Oedema 
Pustules 
Oozing 
Scaling 
Pain 
Ulcers 
Lichenification 
2 
12 
30 
23 
30 
9 
26 
9 
30 
12 
20 
6.6% 
40% 
100% 
76.6% 
100% 
30% 
86.6% 
30% 
100% 
40% 
66.6% 
 
Table shows that itching, pain and oedema were present in all the 
30 cases 
ASSOCIATED HISTORY 
  Since vatha karappan is an immunological disorder other 
associated condition such as  bronchial asthma, Urticaria and hay 
fever were noted in all cases.other commenly encountered 
conditions like hypertension and diabetics were also noted as 
shown below. 
 
 
 
 
 
 
 
Sl.No. History No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
Bronchial asthma 
Hay fever 
Urticaria 
Diabetes 
Hypertension 
- 
- 
5 
2 
1 
- 
- 
16.6% 
6.6% 
3.3% 
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DURATION OF THE ILLNESS BEFORE TREATMENT 
Sl.No. 
Duration in 
months 
No. of 
cases 
Percentage 
1. 
2. 
3. 
 
4. 
5. 
1-3 months 
3-6 months 
6 months – 1 
year 
1 – 2 years 
more than 2 
years 
5 
10 
6 
 
5 
4 
16.6% 
33.3% 
20% 
 
16.6% 
13.3% 
 
DISTRIBUTION OF UYIR THATHUKKAL 
   The derangement of Thathu in Vatha Karappan is tabulated 
as follows 
                                 
DERANGEMENT OF VATHAM 
                                           
  
  
 
 
 
 
 
 
 
 
 
 
Sl.No. Vatham No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
Piranan 
Abanan 
Viyanan 
Uthanan 
Samanan 
Nagan 
Koorman 
Kirukaran 
Devethathan 
Thananjeyan 
- 
2 
30 
- 
30 
- 
- 
- 
- 
- 
- 
6.6% 
100% 
- 
100% 
- 
- 
- 
- 
- 
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DERANGEMENT OF  PITHAM 
          
Sl.No. 
Pitham No. of 
cases 
Percentage 
1. 
2. 
3. 
4. 
5. 
Anar pitham 
Ranjagam 
Sathagam 
Alosagam 
Prasagam 
2 
30 
- 
- 
30 
6.6% 
100% 
- 
- 
100% 
DERANGEMENT OF KAPHAM                                 
Sl.No. Kapham 
No. of 
cases 
Percentage 
1. 
2. 
3. 
4. 
5. 
Avalambagam 
Kilethagam 
Pothagam 
Tharpagam 
Santhigam 
- 
- 
- 
- 
13 
- 
- 
- 
- 
43.3% 
EZHU (SEVEN) UDAR KATTUGAL 
The seven udar kattugal which account for the normal body 
structure, get affected in pathological conditions. They are 
tabulated below 
           
Sl.No. 
Types of udar 
kattugal affected 
No. of 
cases 
Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
Saaram 
Senneer 
Oon 
Kozhuppu 
Enbu 
Moolai 
Sukkilam / 
Suronitham 
30 
30 
26 
26 
- 
- 
- 
100% 
100% 
86.6% 
86.6% 
- 
- 
- 
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ENVAGAI THERVUGAL  
In the siddha system of medicine eight investigative 
procedures were followed for clinical approach and diagnosis. These 
methods were strictly followed in all the cases and observations  
noted. 
                                
Sl.No. 
Type of 
investigations 
No. of 
cases 
Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
 
 
8. 
Naa 
Niram 
Mozhi 
Vizhi 
Malam 
Moothiram 
Naadi 
a) vatha pitham 
b) vatha kapam 
Sparisam 
- 
30 
- 
- 
2 
- 
 
21 
9 
30 
- 
100% 
- 
- 
6.6% 
- 
 
70% 
30% 
100% 
 
NEERKURI, NEIKKURI  
 
Sl.No. Type of test 
No. of 
cases 
Percentage 
1. 
 
2. 
 
 
 
Neerkuri 
    “Vaikkol Niram” 
Neikuri 
a) Muththoththu 
nitral(kabam) 
b) Aravena 
neendathu(vatham) 
30 
 
 
2 
 
28 
100% 
 
 
6.6% 
 
93.3% 
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RESULTS AFTER TREATMENT 
 Out of these 30 cases 20 cases were showed good relief. 
                                  
Sl.No. Results No. of cases Percentage 
1. 
2. 
3. 
Good relief 
Moderate relief 
No  relief 
20 
9 
1 
66.6% 
30% 
3.3% 
 
0
10
20
30
40
50
60
70
80
GOOD RELIEF MODERATE RELIEF
RESULTS
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                        LIST OF IP PATIENTS 
 
S.NO IP. 
NO 
NAME AGE / 
SEX 
D.O.A D.O.D NO.OF 
DAYS 
TREATED 
RESULT 
1. 979 Gopal 77/M 02.12.07 07.01.08 37 C 
2. 991 Alphonse 55/M 11.12.07 04.01.08 25 C 
3. 992 Subibiramani 45/M 12.12.07 12.1.08 31 I 
4. 1135 Kanniyapan 66/M 20.2.08 27.3.08 36 I 
5. 1125 Ethiraj 55/M 18.02.08 8.03.08 23 I 
6. 1164 Jyothi 46/M 5.3.08 29.3.08 25 C 
7. 1082 Arjun 45/M 31.01.08 25.02.08 26 C 
8. 1169 Ravi 39/M 10.3.08 9.4.08 30  I 
9. 1173 Adaikalam 60/M 10.3.08 29.3.08 20 C 
10. 1212 Mani 19/M 27.3.08 5.5.08 40 C 
11. 1221 Chinnasamy 45/M 31.3.08 27.4.08 28 N.C. 
12. 1254  Subbiramani 65/M 10.4.08 10.5.08 31 I 
13. 675 Vasanthi 24 / F 29.12.07 24.01.08 27 C 
14. 693 Kanniyamma 60 / F 10.01.08 06.02.08 27 I 
15. 716 Sobitham 47 / F 24.01.08 21.02.08 28 C 
16. 745 Radha 60 / F 12.02.08 05.03.08 22 C 
17. 759 Vijayalakshmi 37 / F 18.02.08 08.03.08 20 C 
18. 725 Rani 61 / F 29.01.08 27.02.08 30 C 
19 711 Anjala 57 / F 23.01.08 08.02.08 16 I 
 
C – Cured 
NC – No Change 
I – Improved 
D.O.A – Date of Admission 
D.O.D. – Date of Discharge 
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LIST OF OP PATIENTS 
 
 
S. 
NO 
OP NO NAME AGE / 
SEX 
D.O.A D.O.D NO.OF 
DAYS 
TREATED 
RESULT 
1. AD 7211 Thabitha 25 / F 21.11.07 29.01.08 48 C 
2. 21651 Elisabeth 47/ F 21.11.07 12.01.08 51 C 
3. 4427 Vasanthi 44 / F 28.11.07 20.12.06 48 C 
4. AD 9933 Dean Samuvel 42 / M 5.12.07 31.01.08 48 C 
5. AB 976 Pulli Narayana Samy 71 / M 17.11.07 31.03.08 48 C 
6. AA 9122 Jayaraman 60 / M 07.12.07 19.12.07 48 I 
7. AE 5607 Godhandam 59 / M 09.02.08 27.03.08 48 C 
8. AG4693 Muniyamma 55 / F 06.02.08 25.03.08 48 C 
9. AE 7968 Christopher 49 / M 04.02.08 23.03.08 48 I 
10. AE 9599 Subbiramani 65 / M 17.12.07 24.01.08 48 C 
11. AC 7731 Shankar 36 / M  12.12.07 29.01.08 48 C 
 
 
C-cured; 
I-Improved 
D.O.A – Date of Admission 
D.O.D. – Date of Discharge 
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Clinical laboratory investigations-I.P 
Haematological investigations 
SI 
NO 
IP 
NO 
TC(Cumm) DC  (Cumm) 
 
      Hb 
    (mg/dl) 
Blood Sugar 
(mgs%) 
ESR  (mm) 
BT AT              BT%              AT% BT AT BT AT BT AT 
P L E M P L E M F PP F PP 1/2hr 1hr 1/2hr 1hr 
1. 991 8400 4000 52 42 6 - 53 44 5 - 12.2 14.2 86 100 70 111 13 28 6 12 
2. 979 8000 7000 54 40 6 2 50 42 6 2 9.3 8.2 74 110 85 107 40 60 30 60 
3. 992 7800 6200 55 42 2 1 50 43 6 1 12.4 12 81 111 68 107 36 70 20 40 
4. 675 7600 9000 53 42 4 1 50 43 5 2 12 9.7 67 111 88 104 16 36 45 90 
5. 711 5200 7000 50 42 6 2 54 40 4 1 9.7 10.0 96 116 90 100 17 35 10 20 
6. 1135 5900 8000 60 38 2 - 54 40 4 2 10.6 12.5 88 154 61 111 9 18 2 4 
7. 1173 7000 8000 55 40 5 - 54 42 4 2 13.2 13.0 90 143 62 134 8 16 10 20 
8. 1169 6200 8600 56 38 5 1 65 30 5 - 13.6 15 96 153 90 150 2 4 6 12 
9. 1164 7800 8000 50 30 2 - 53 44 3 - 14.14 10 70 108 63 92 15 30 4 8 
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10. 1082 8000 8400 54 40 6 - 50 42 6 - 12.00 12.2 98 100 90 110 20 30 8 12 
11. 1125 6800 7800 52 46 2 - 62 36 2 - 12.2 14.4 89 180 72 107 2 4 3 6 
12. 1212 7200 7000 56 42 2 - 50 42 4 2 14.5 14.6 60 87 86 116 2 4 10 20 
13. 1221 7400 8600 61 31 8 - 56 39 5 - 13 15.5 99 123 94 122 24 48 22 44 
14 1254 7600 6600 52 41 7 - 54 43 2 - 11 10 87 153 132 188 22 44 6 12 
15. 693 7700 7600 50 38 5 1 50 46 3 1 12.6 12.1 108 166 104 230 30 44 10 22 
16. 716 7600 7800 60 35 4 1 53 32 3 1 9.7 10 76 96 90 100 10 25 3 8 
17. 725 7600 9600 52 40 6 2 58 38 4 - 12.1 11.4 64 136 90 206 15 32 10 20 
18 745 7600 7200 57 38 5 - 56 40 4 - 12.1 12.5 118 254 98 236 20 42 9 20 
19 759 7400 8000 54 40 5 1 56 30 2 - 12.1 14.4 70 155 79 110 30 60 40 80 
 
BT-Before treatment ; AT-After treatment; P-Polymorphs; L-Lymphocytes; E-Esinophils; M-Monocytes; F-Fasting; PP-
Post prondial. 
Anemic-3cases; 
Blood sugar level is increased in 4cases; 
TC level is increased in 12 cases; 
Esinophil level is decreased in 10 cases; 
ESR level is decreased in 11cases. 
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Clinical laboratory investigations-O.P 
                                                  Haematological investigations 
 
I 
NO 
OP 
NO 
TC(Cumm) DC  (Cumm) 
 
      Hb 
    (mg/dl) 
Blood Sugar (mgs%) ESR  (mm) 
BT AT              BT%              AT% BT AT BT AT BT AT 
P L E M P L E M F PP F PP 1/2hr 1hr 1/2hr 1hr 
1. AD7211 8100 8600 50 45 05 - 50 45 5 - 11.9 12.5 - 108 - 110 6 15 7 14 
2. Z1651 6600 8600 46 48 06 - 38 50 08 - 11 11.1 77 116 100 - 30 40 28 54 
3. 4427 7600 7400 57 40 03 - 54 40 06 - 12.5 9.2 92 - 75 - 7 6 12 24 
4. AD9933 9800 8600 54 43 02 01 50 40 02 - 16.5 16 85 - 100 - 12 25 8 6 
5. AB976 7600 7300 50 42 06 - 48 50 02 - 7.3 9.2 71 - 78 - 12 24 3 7 
6. AA9122 7400 5900 52 42 05 - 56 40 04 - 12.2 11 79 100 81 108 30 60 18 20 
7. AE5607 5900 7800 50 48 02 - 58 37 05 - 11.7 11.6 66 136 98 - 2 5 6 12 
8. AG4693 7900 8200 52 46 02 - 50 48 02 - 12 13.7 74 114 80 110 12 26 6 10 
9. AE7968 6200 7600 54 40 4 - 60 40 03 - 12.1 12.4 108 - 110 - 7 16 7 10 
10. AE9599 6300 9000 49 46 04 01 60 36 03 - 14.5 12.1 81 111 72 136 4 8 10 20 
11. AL7731 8700 6900 59 38 03 - 50 47 03 - 15.5 15 91 - 74 - 2 4 2 6 
 
BT-Before treatment ; AT-After treatment; P-Polymorphs; L-Lymphocytes; E-Esinophils; M-Monocytes; F-Fasting; PP-Post prondial. 
Anemic-2cases;  TC level is increased in 6 cases;    Esinophil level is decreased in 4 cases;    ESR level is decreased in 4 cases.
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Urine analysis -  OP 
 
SLNO OPNO BEFORE TREATMENT AFTER TRTEATMENT 
SUGAR SUGAR 
FASTING POSTPRONDIAL FASTING POSTPRONDIAL 
1. AD 7211 NIL NIL NIL NIL 
2. 21651 NIL NIL NIL NIL 
3. 4427 NIL NIL  NIL NIL 
4. AD 9933 NIL NIL NIL NIL 
5. AB 976 NIL NIL NIL NIL 
6. AA 9122 NIL NIL NIL NIL 
7. AE 5607 NIL NIL NIL NIL 
8. AG4693 NIL NIL NIL NIL 
9. AE 7968 NIL NIL NIL NIL 
10. AE 9599 NIL NIL NIL NIL 
11. AC 7731 NIL NIL  NIL NIL 
 
 
Urine analysis -  IP 
 
SLNO IPNO BEFORE TREATMENT AFTER YTRTEATMENT 
SUGAR SUGAR 
FASTING POSTPRONDIAL FASTING POSTPRONDIAL 
1. 979 NIL NIL NIL NIL 
2. 991 NIL NIL NIL NIL 
3. 992 NIL NIL  NIL NIL 
4. 1135 NIL NIL NIL NIL 
5. 1125 NIL NIL NIL NIL 
6. 1164 NIL NIL NIL NIL 
7. 1082 NIL NIL NIL NIL 
8. 1169 NIL NIL NIL NIL 
9. 1173 NIL NIL NIL NIL 
10. 1212 NIL NIL NIL NIL 
11. 1221 NIL NIL  NIL NIL 
12. 1254   NIL NIL NIL NIL 
13. 675 NIL NIL NIL NIL 
14. 693 NIL NIL  NIL NIL 
15. 716 NIL NIL NIL NIL 
16. 745 NIL NIL NIL NIL 
17. 759 NIL NIL NIL NIL 
18. 725 NIL NIL NIL NIL 
19 711 NIL NIL NIL NIL 
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DISCUSSION 
 
For this dissertation study out of 30 patients selected by the 
author. 19 patients were admitted in the inpatient ward of 
Ayothidoss Pandithar Hospital of National Institute of 
Siddha,chennai. Case sheets were  prepared and maintained 
individually for all the 19 inpatients.  
The triggering factors like the climate influences, 
psychological disturbances, etc., were also studied. Daily 
observations were made before, during and at the end of the study. 
The observations are discussed as follows. 
 
Sex distribution 
In the study among the 30 cases, 19 were males and 11 were 
females. According to the siddha literature, there is no apparent sex 
predilection in vatha karappan. 
 
Age distribution 
During this entire study, the prevalence of Vatha karappan 
was a very common one affecting the adult age group mainly above 
50 years.  
 
Kaalam (Life Span) distribution:  
 
Out of 30 patients 
70% of the patients belonged to pitha kaalam 
20% of the cases belonged to Kapha kaalam 
10% of the patients belonged to vatha kaalam 
This research study shows that majority of patients were 
affected in their pitha kaalam. 
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Occupational status 
Occupational hazards play an important role in causing or 
aggravating the disease vatha karappan.  
 
Socio – economic condition 
Out of 30 patients, 14  were belonged to poor economic 
conditions, Majority of them were ignorant in personal hygiene. 
Malnutrition, prolonged & persistant exposure to polluted 
atmosphere, lowered immune responses made them  prone to this 
type of disease. 
 
Diet  
According to siddha literature the non-vegetarian diet 
accounts much more for the occurrence of the vatha karappan. 
Here during the study 96.6% of patients were Non-vegetarians . 
Again some food stuffs like raggi, bitter guard, brinjal, maize, 
tomato and fish items can also be causative factors for the vatha 
karappan. So they were advised to avoid such food items. 
 
Paruva kaalam(Season) 
Skin diseases have definite seasonal influences. Out of 30 
cases, 11 cases (36.6% ) belonged to Koothir kaalam (October to 
December) , 9 cases ( 30%) belonged to Munpani kaalam  
(December to February ) , 5 cases (16.6% ) belonged to pin pani 
kaalam (February to April),and 5cases ( 16.6%)  belonged to 
Elavenil kaalam ( April to June). 
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Thinai  (Land and place) 
100% of cases belonged to Neithal  nilam. This may be due to 
the environmental pollution caused by the advancement of science 
& technology, life style and the use of too much of pesticides and 
chemicals. 
 
Gunam  
Thirty cases had Rajogunam. From this inference character is 
very much important in developing disease. This was clearly stated 
in the siddha system. So control of mind and restoration of normal 
life style can lead to reduction in the incidence of disease. 
 
Mode of onset 
During the study 80% cases were observed to be the chronic . 
Incomplete treatment, failure to follow medical advice and dietary 
restrictions, psychological strains and changed life style were 
observed to be the reasons for this disease to become chronic.  
 
Aetiology 
All types of aetiological factors were observed during the 
study. Here no positive family history was found. Occupational 
relevance was observed in 13 cases. 
  Insect bite  (5 cases) and psychological stress and strain (12 
cases) were also noted. 
Mukkutram  
a) Vatham 
Among the 30 patients Abanan was affected in 2 cases 
(habitual constipation).  Viyanan and Samanan were affected in all 
cases. 
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b) Pitham 
Among 30 cases, Anarpitham was affected in 2 cases  (loss of 
appetite, indigestion)  Ranjagam and Prasagam was affected in all 
cases (due to dryness, roughness and hyperpigmentation of the 
skin). 
 
c) Kapham 
   Santhigam (joint pain) was affected in 13 cases.  
 
Ezhu (seven) Udar Kattugal   
Among the 7 udar kattugal, saaram was affected in all cases   
(depression, anhidrosis, etc) senneer was affected in 100% of cases 
(papules, vesicles, lassitude, anemia). Oon and kozhuppu were 
affected ( ulcers, joint pain)  in 13 cases. 
 
Envagai Thervugal  
Among 30 cases, niram and sparisam were affected in all 
cases. In Naadi nadai, vatha pitham was found in 21 cases and 
vatha kapham was found in 9 cases. 
 
Mode of action 
Each and every drug contains five kinds of actions i.e suvai 
(Í¨Å), gunam (Ì½õ), veeriyam (Å£Ã¢Âõ), pirivu (À¢Ã¢×) and mahimai 
(Á¸¢¨Á). All these five are based on five elements (pancha boothas) 
which are present in the drug. 
Normalization of the 3 thathus (Vatha, Pitha, Kapha) is a cure 
to the disease. Karappan occurs as a result of derangement of 
Kapham. Sangan chooranam had kaippu suvai which brings the 
deranged kapham to normal. 
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19 patients were admitted in the inpatient ward to facilitate 
frequent supervision. All the patients were treated with vatha 
karappan chooranam (internal) and aamanakku ennai (external) for 
an average of 20 days. The improvement was observed from the 
third day onwards in acute and 8-10days in chronic cases. The 
number of days taken for complete disappearance of the symptoms 
varied from case to case. 
In this study, vatha karappan chooranam (internal) and 
aamanakku ennai (external) were found to be more effective  
clinically.  
 
Pharmacological analysis of  Vatha karappan chooranam 
shows  
 Significant anti- histamine action. 
 Moderate acute and chronic anti- inflammatory action. 
 Mild analgesic action. 
 The patients who had hypertension (one case) and diabetes  
(2 cases), were already under going allopathic treatment for 
hypertension and diabetes and were advised to continue the 
treatment, during the admission period. 
It was observed that there were no  adverse effects during the 
entire course of treatment in all the 30 cases. 
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SUMMARY AND CONCLUSION 
 
 The trial drugs were selected from “Agasthiar Ayul vetham” 
Clinical trial was conducted in 30 cases from both sexes of  
     different age groups. 
 Before starting the treatment careful detailed history was 
taken. 
 They were treated with ‘Vathakarappan chooranam’ 
internally and ‘Amanakku ennai’ externally. 
 Along with medication the patients were advised to follow a 
dietary regimen and to practise pranayama. 
 History, clinical findings, laboratory results, Envagai 
thervugal and uyir thathukkal were used for the diagnostic 
purpose.  
 The general improvement in the condition of the patients 
were observed from the end of the first week itself. On an 
average of 20 days of treatment, all the patients showed 
satisfactory relief generally. 
 Most of the patients showed encouraging results.  
 The drugs were found to be free from adverse effects during 
the entire course of treatment. 
 The herbs are available in almost all season and 
preparation of medicine is very simple. 
Finally the ingredients of this trial drugs are cost effective 
and this will be helpful in promoting large scale manufacture of 
the drugs, latering to medical needs of large number of patients. 
These merits are essential in promoting this drug in future 
globally. The author hereby concludes that the skin disease 
“Vatha karappan” can be encouragingly treated with the trial 
drugs. 
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ANNEXURES 
Preparation of the Trial Drug  ( Internal) 
thjfug;ghd; R+uzk; 
NrUk; kUe;Jfs;: 
 J}Jtis NtH 
 Xhpjo; NtH 
 vUf;F NtH 
 nfhbNtyp NtH    
 fLf;fha; rkmsT 
 fUQ;rPufk; 
 fhl;Lr; rPufk; 
 Rf;F 
 Vyk; 
 mKf;fpuh 
nra;Kiw: 
 Nkw;fz;l ruf;Ffis Rj;jpj;J ,bj;Jr; rypj;J R+uzpj;Jf; nfhs;sTk; 
msT: 1-2 fpuhk; fhiy> khiy ,UNtis  cs;Sf;F 
mDghdk; : nty;yk; (rkmsT) 
jPUk; Neha;:  thjfug;ghd; 
Mjhuk; - mfj;jpaH MAs; Ntjk;. 
        Preparation of the Trial Drug  ( External) 
             Mkzf;F vz;nza;; 
NrUk; ruf;Ffs; 
 nea; 
 ey;nyz;nza; 
 Mkzf;F vz;nza; 
 Ntg;ngz;nza; 
Njq;fha; vz;nza; 
 kQ;rs; nghb – rpwpjsT 
nra;Kiw: 
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 Nkw;fz;l vz;nza;fs;> nea;iar; NrHj;J fha;r;rp gpd; mjpy; kQ;rs; nghb NrHj;J 
Mwpa gpd; tbfl;bf; nfhs;sTk;. 
gad;: 
 ntspg;gpuNahfkhfg; gad;gLj;.j thj fug;ghd; jPUk;. 
   Mjhuk; - mfj;jpaH MAs; Ntjk;. 
 
 
PREPARATION OF TRIAL DRUGS 
thjfug;ghd; #uzk; 
 
 
 
 
 
 
 
                       Mkzf;F vz;nza; 
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INCREDIENTS OF VATHA KARAPPAN CHOORANAM 
Calotropis gigantean (L) R.Br          Solanum trilobatum. Linn 
Eletariacardamomum                        Vernonia anthelmintica 
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Terminalia Chebula. Retz Nigella Sativa 
 
  
 
 
 
 
 
 
 
 
 
 
 
Hybanthus enneaspermus                                                       Plumbago Zeylanica 
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Withania Somnifera                                           Zingiber officinale. 
 
 
  
 
 
 
 
 
Properties of the Trial Drug 
J}Jtis: 
 jhtutpay; ngaH  : Solanum trilobatum. Linn 
 gad;gLk; cWg;G : NtH 
 Rit   - rpWifg;G> fhHg;G 
 jd;ik  - ntg;gk; 
 gphpT   - fhHg;G 
 nra;if  - ntg;gKz;lhf;fp> Nfhioafw;wp> cukhf;fp 
 
nghJf;Fzk; : 
 J}JNt isiaAzj; njhf;fpdpw; nwhf;fpa 
 Ntijah Nehnayh nka;iatpl; lfYNk 
      (NjiuaH fhg;gpak;) 
gad;fs;: 
 J}JNtisia> fw;gKiwahfNtDk;> fwpahfNtDk; cl;nfhz;L tu clypy; Vw;gl;l 
Neha;fs; ahTk; ePq;Fk;. 
,J xU fw;g kUe;J. 
Constituents: 
 The major glyco alkaloid present in the plant β Solamarine  
Uses: 
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 The plant exhibited anti bacterial antifungal, activities.  It showed 
promising results in the two cancer test systems KB cell and sarcoma 
180 in mice. 
Indian Materia Medica, 
Dr.Nadkarani. 
Xhpjo; jhkiu: 
 
 jhtutpay; ngaH : Hybanthus enneaspermus 
 gad;gLk; cWg;G : NtH 
 Rit   : ,dpg;G 
 jd;ik   : jl;gk; 
 gphpT   : ,dpg;G 
 nra;if  : clYukhf;fp 
 
nghJf;Fzk;: 
jhJitazlhf;Fe;  jdpNkfj;ijj; njhiyf;Fk;  
Mjuth Nkdpf; foFjUQ; - rPjk;Nghk; 
rPupjo;j; jhkiu tho; nra;a kltdNk  
Xupjo;j; jhkiuia Az; 
    - Fzghlk;  %ypif tFg;G 
 
gad;fs;: 
 NkfNeha;, Gz; jPUk;. clYf;F moF jUk;. ,J xU fw;g kUe;J. 
Contituents: 
 There is an alkaloid used in Scorpion sting. 
Uses: 
 Tonic, diuretic and  demulcent. 
Indian Materia Medica, 
Dr.Nadkarani. 
 
nfhbNtyp 
jhtutpay; ngaH - Plumbago zeylanica 
 gad;gLk; cWg;G - NtH 
 Rit   - fhHg;G  
jd;ik  - ntg;gk; 
 gphpT   - fhHg;G  
nra;if  - Kiw ntg;gfw;wp  
nghJf;Fzk; 
 71
 “fl;b tpuzq; fpue;jp fhy;fs; miuahg;Gf; 
 fl;bf;R+iy tPf;fq; fho;%yk; - Kl;buj;jf; 
      - mfj;jpaH Fzthflk; 
 “fl;bNa R+iyf;fl;L fUjpL Fwpg;Gz; fpue;jp 
 xl;LNk fuzj;NjhL KWkiuahg;G kd;wp 
- VL 
gad;fs;: 
 ,jdhy; fl;b > Gz;> foiy> tspNeha;> miuahg;Gf;fl;b> jPUk;.  NkYk; 
,jdhy; R+iyf;fl;L> Fwpg;Gz;> fpue;jp> Nkfg;Gz;> newpRuk; KjypaitAe; jPUk;. 
Constituents      
Plumbagin, Free glucose, Fructose and Enzymes like  Protease and 
Invertase. 
Uses: 
 Root reduced to a paste is applied to abscesses with the object to 
opening them.  With milk, vinegar, or salt and water the paste  may be 
applied in leprosy and other obstinate skin diseases unhealthy ulcers, 
scabies etc.    Plumbagin has well marked antiseptic properties.  
Indian Materia Medica, 
Dr.Nadkarani. 
                                                             vUf;F 
jhtutpay; ngaH :  Calotropis gigantean (L) R.Br 
gad;gLk; cWg;G :  NtH  
Rit - ifg;G> fhuk;> ,dpg;G 
jd;ik - ntg;gk; 
gphpT - fhHg;G 
nra;if  :      clw;Njw;wp, Nfhioafw;wp  
nghJf;Fzk; 
 ‘kd;didAq; ifnaLf;f itj;njapw;wp Ndafw;wp 
 Ad;D gpzpg;gzpia Nahl;L;jyhw; - nrhd;Ndd; 
 vUf;nfdNt G+kp apdpNy  tpsq;Fk; 
         mUf;f kUf;fndd yhk;'    
- Njud; ntz;gh  
gad;fs;  :   ,J xU fw;g kUe;J.tsp Neha;fSf;F ed; kUe;J MFk;. 
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Constituents 
Aerial parts contain flavonol glycosides colotropiside.  
Root bark contains β – amyrin, 2 isomeric crystalline alcohols, 
giganteol and iso- giganteol. 
Stem bark contains resinols α and β calotropols, fatty acids. 
Latex contains α – amyrin. 
The ash of calotropin gigantea is rich in potash (20.8%).  
uses 
Root, bark, flower, leaf, latex are used in convulsions, disease 
of Vatham and Kapham, Leprosy, swelling in joints, worm 
infestation, skin disease, dyspnoea. 
Indian Materia Medica, 
Dr.Nadkarani. 
 
 
 
 
 
 
 
 
fLf;fha; 
 
 jhtutpay; ngaH : Terminalia chebula. Retz 
 gad;gLk; cWg;G : fha; 
 Rit   : JtHg;G> rpwpJ ,dpg;G> Gspg;G> 
     fhHg;G> ifg;G 
 gphpT   - ,dpg;G 
 nra;if  - grpj;jPj;J}z;b> kykpsf;fp 
nghJf;Fzk;: 
 jhil fOj;jf;fp jhY Fwpaptplg; 
 gPil rpypgjKw; NgjpKlk; - Milnal;lhj; 
 J}ykpb Gz;thj Nrhzpfh khiyapuz; 
 lhykpb Nghk;thpf;fh ahy; 
    (mfj;jpaH Fzthflk;) 
gad;fs;: 
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 GONeha;fs;> Fl;lk;> fhkhiy> epwk;khWgLjy;> NkfNuhfk;> Gz;> fpue;jp> 
gTj;jpuk;> kz;ilg;Gw;W> kz;ilf;fpue;jp> tha;g;Gz; Kjypa Neha;fs; jPUk;. 
 
Constituents: 
 Tanins, anthraquinones, chebulinic acid, chebulagic acid, chebulic 
acid, enagic acid and gallic acid. 
Uses:  
It is used externally as a local application to chronic ulcers and 
wounds. 
Indian Materia Medica, 
Dr.Nadkarani. 
fhl;Lr;rPufk;   
jhtutpay; ngaH    : Vernonia anthelmintica.willd. 
gad;gLk; cWg;G  - tpij  
Rit    - ifg;G 
gphpT    - fhHg;G 
jd;ik           -  ntg;gk; 
nra;if: grpj;jPj;J}z;b> cukhf;fp> rpWePHg;ng&f;fp> Kiw ntg;gfw;wp>           
        clw;Nww;wp. 
   
nghJf;Fzk;: 
 iffWg;G khWq; fbaNk fk;NghFk; 
 nka;FspUk; gpj;jk; tpisANkh – nta;afhpf 
 Nfhl;Lg; gizKiyaha; Fd;kth je;njhiyAq; 
 fhl;Lew; rPufj;ijf; fhz;. 
                         -  Fzghlk; %ypif tFg;G 
 
gad;fs;: 
cs;sq;iff; fUk;Gs;sp jPUk;> ntz;Fl;lk;> nrhwp rpuq;F jPUk;. 
 
 
Constituents: 
 Seed contains resins, an alkaloid  known as vernoninea. 
Uses: 
 Seeds are used in leprosy, skin diseases like psoriasis. 
Indian Materia Medica,  Dr.Nadkarani.                     
fUQ;rPufk; 
 jhtutpay; ngaH    - Nigella sativa 
gad;gLk; cWg;G  - tpij  
 Rit    - ifg;G 
 jd;ik    - ntg;gk; 
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 gphpT    - fhHg;G 
 nra;if   - Anthelmintic, Parasiticide and Diruetic. 
 nghJf;Fzk;: 
  “fUQ; rPufe;jhd; fug;ghndhLGz;Zk; 
  tUQ; rpuha;g; gPerK khw;Wk;  mUe;jpdhy; 
  fha;r;ry; jiytypAk; fz;typAk; NghKyfpy; 
  tha;r;r kUe;njdNt it” 
- mfj;jpaH Fzthflk; 
gad;fs;: 
,jdhy; fug;ghd;> Gz;> gPerk;> fha;r;ry;> jiytyp> fz;typ Mfpad                   
jPUk;. 
 
Constituents: 
  Essential oil, Fixed oil, Amorphous,Glycosidal, Saponin, 
Melanthin. 
Uses: 
             Puerperal fever,Scorpion sting  
Indian Materia Medica, 
Dr.Nadkarani. 
Rf;F 
 
jhtutpay; ngaH : Zingiber officinale. 
gad;gLk; cWg;G : fpoq;F (cyHe;jJ) 
Rit   - fhHg;G 
jd;ik  - ntg;gk; 
gphpT   - fhHg;G 
nra;if  - ntg;gKz;lhf;fp 
grpj;jPj;J}z;b> mfl;Ltha; mfw;wp 
 
nghJf;Fzk;   
  
R+iyke;jk;> neQ;nrhpg;G NjhlNkg;g koiy 
 %yk; ,iug;gpUky;> %f;FePH thyfg 
Njhlkjp rhue; njhlHthj Fd;kePHj; 
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Njhlk;M kk;Nghf;FQ; Rf;F 
   (mfj;jpaH Fzthflk;) 
gad;fs;: 
 nrhpahik, fPo;tha; Neha;, ,Uky;> IaRuk; Nghk; 
 
 
Constituents: 
 The dried ginger rhizomes contain the anti-ulcer compounds, β- 
sesquiphellandrene, - β - bisabolene, arcur cumene and shagol. 
 
Uses: 
Ginger is used to restore blood circulation and colour.It has anti –   
inflammatory,immunomodulatory and anti – atherosclerotic actions.The 
rhizome is used to heal wound.  It produces anti – ulcer effect. 
Indian Materia Medica, 
Dr.Nadkarani. 
Vyk; 
jhtutpay; ngaH       -  Eletaria cardamomum 
gad;gLk; cWg;G  -  tpij 
Rit    . fhHg;G 
jd;ik   - ntg;gk; 
gphpT    - fhHg;G 
nra;if   - ntg;gKz;lhf;fp> mfl;Ltha;tfw;wp> 
     grpj;jPj;J}z;b 
nghJf;Fzk; 
 
 njhz;il tha;fTs; jhYF jq;fspy; 
  Njhd;Wk; Nehajp rhuk;gd; Nkfj;jhy; 
 cz;il Nghy;vOq; fl;b fphpr;ruk; 
  coiy the;jp rpye;jp tp\Q;Ruk; 
  
gz;il ntf;if tpjhfNeha; fhrKk; 
  ghOQ; Nrhkg; gpzptpe;J el;lKk; 
 mz;il aPistd; gpj;jk; ,itf;nfy;yhk; 
  My khq;fko; Vy kUe;jNj 
     (NjiuaH Fzthflk;) 
gad;fs;: 
gd;Nkfj;jhy; vOk; fl;b> rpye;jp eQ;R ,tw;iwg; Nghf;Fk; moiy Mw;Wk; 
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Constituents: 
 Cineol, Terpineal, Terpinene, Limonene, Sabinene. 
 
Uses: 
 Diuretics, Carminative, Anti-inflammatory. 
Indian Materia Medica, 
Dr.Nadkarani. 
mKf;fuh 
 jhtutpay; ngaH - Withania somnifera 
     gad;gLk; cWg;G - NtH. 
 Rit   - ifg;G 
jd;ik  - ntg;gk; 
gphpT   - fhHg;G 
 
nra;if: 
clw;Njw;wp, tPf;fKUf;fp, rpWePu;ngUf;fp, cwf;fKz;lhf;fp.  
Constituents: 
 Anaferin is a ketone, Pyrazole, Withanine and Somniferine are  
alkaloids which are present in this plant.  
Uses: 
 Root is used as application in obstinate ulcers and rheumatic 
swellings.  Leaves are used as an anthelmintic and as an application to 
carbuncles. 
Indian Materia Medica, 
Dr.Nadkarani. 
nghJf;Fzk;:                        
 “nfhQ;re; JtHg;ghq; nfhba fgk; R+iyahp 
 kpQ;R fug;ghd; ghz;L ntg;gjg;G – tpQ;rp 
 KRTW NjhlKk;Ngh Nkfk; mdYz;lhk; 
 mRtfe;jpf;nfd; wwp” 
      - mfj;jpaH Fzthflk; 
gad;fs;: 
 fak;,tspf;$l;lq;fs; fug;ghd; Ruk; tPf;fk; ,itfisg; Nghf;Fk;. ,J xU fw;g kUe;J. 
gRnea;  
nghJFzk; 
jhfKo iyRl;fk; the;jp gpj;jk; thAgpu 
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Nkfk; tapw;nwupT tpf;fyoy; - khfhrq;  
Fd;kk; tul;rp Flw;Gul;l y];jp Rl;fQ; 
nrhd;%yk; Nghf;Fepiwj; Jg;G. 
                         -  Fzghlk; jhJ rPt tFg;G 
gad;fs; 
jhfk;, coiyg;gpzp, mjpRl;fNuhfk;, the;jp, gpj;jhjpf;fk;, thjtp\k; tpuzg;gpuNkfk;,  
tapw;nwupT, tul;rp,  %yk; Mfpatw;iw ePf;Fk;. 
Mkzf;nfz;nza;: 
jhtutpay; ngaH  : Ricinus communis. Linn 
gad;gLk; cWg;G  : tpij, vz;nza; 
Rit    : ifg;G 
jd;ik   : ntg;gk; 
gphpT    : fhHg;G 
nra;if   : thjklf;fp 
nghJf;Fzk;: 
           Mkzf;F nea;ahy; eyKz;lhk; ahtUf;Fk;  
  G+kzf;F NkdpGupFoNy -  tha;kzf;ff;  
  nfhs;spy; tapW tpLq; NfhuKs;s thAtWk; 
  cs;spy; tU Fd;kk;Ngh NkhJ.  
     - mfj;jpaH Fzthflk;             
gad;fs;: 
 ,jd; tp;ijia Xl;il ePf;fp> miuj;J fl;bfspd; kPJ itj;Jf; fl;btu> fl;bfs; vspjpy; gUj;J 
cilAk;. 
 Mkzf;F vz;nza;ia Kiyf;fhk;Gg; Gz;> Kiyf;fhk;G ntbg;G ,itfSf;F rPiyapy; 
eidj;Jg; Nghl;Ltug; Nghk;. 
 clk;gpy; Nky; Njhy; cuha;e;J FUjpf; Fok;gf; fz;lhy;> Mkzf;F vz;nza;iaj; jlt 
vhpr;ry; ePq;Fk;. 
 
 
Constituents:  
Ricinine, tonalbumin, Ricin, Ricinoleic acid, Stearic acid, and small 
quantity of Palmitine. 
 
Uses:  
             It is used to treat Peritonitis, Piles, Scorpin-sting. 
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                                                                    -Indian Materia Medica, 
Dr.Nadkarani. 
Ntg;ngz;nza;: 
jhtutpay; ngaH : Azadirachta indica.  
gad;gLk; cWg;G : tpij, vz;nza; 
Rit   : ifg;G 
jd;ik   : ntg;gk; 
gphpT   : fhHg;G 
nra;if  : GOf;nfhy;yp> mOfyfw;wp> ntg;gKz;lhf;fp 
nghJf;Fzk;: 
 “Ntk;gpd; tpijf;F kplrd;dp ghjKjy; 
 Njk;gptpOe; NjhLnkdj; NjH” 
    - mfj;jpaH Fzthflk; 
gad;fs;: 
 ,jd; gUg;ig miuj;Jg; GOg;gl;l Gz;fSf;Fg; G+r Gz;zpd;W GOf;fs; ntspg;gLk;.  
Gz; MWk;. 
 Ntk;gpd; nea;iag; G+r> ngUk; tsp Neha;fs;> foiyfs;> fug;ghd;> rpuq;F ,itfs; 
Nghk;. 
Constituents: 
 Nimbin , Nimbinin, Nimbidin, Sulphur. 
Uses: 
 It is used Externally for the skin infections like Eczema, Ringworrm & 
Scabies.                                              
                                                           -Indian Materia Medica, Dr.Nadkarani 
Njq;fha; vz;nza;: 
 jhtutpay; ngaH : Cocus nucifera 
 gad;gLk; cWg;G : Njq;fha; , vz;nza; 
 Rit   : ,dpg;G 
jd;ik  : jl;gk; 
gphpT   : ,dpg;G 
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nghJf;Fzk;: 
Njq;fhap nza;ajdhw;wPahy; tUGz;Nghk; 
ghq;fhff; $e;jw; glHe;NjW – ePq;fhj 
gy;ybapd; NdhAk; glHjh kiu rpuq;Fk; 
my;ywg; Nghnkd;wwp.; 
-  Fzghlk; %ypif tFg;G 
gad;fs; 
 Njq;fha; nea;ahy;> jPg;gl;l Gz;Zk;> gy;Neha;> glHjhkiu> rpuq;F Mfpaitfs; 
Nghk;. 
 
Constituents: 
 Caprylic acid, Lauricacid, Myristic acid , Palmitic acid , Stearic 
acid. 
Uses: 
 
 A tarry oil is prepared from the shell of the nut which is used  only 
externally in the  treatment  of  ring worm. Oil  is used for boils. 
-Indian Materia Medica, 
Dr.Nadkarani 
¿ø¦Äñ¦½ö 
 þó¦¿ö ±ûÇ¢Ä¢ÕóÐ ±Îì¸ôÀÎ¸¢ÈÐ. 
±û 
¾¡ÅÃÅ¢Âø ¦ÀÂ÷ : Sesamum indicum Linn. 
gad;gLk; cWg;G : tpij, vz;nza; 
Í¨Å   : þÉ¢ôÒ 
¾ý¨Á  : ¦ÅôÀõ 
À¢Ã¢×   : þÉ¢ôÒ 
nra;if         :      ¯ûÇÆÄ¡üÈ¢, ¯ÃÁ¡ì¸¢,ÁÄ¸¡Ã¢, ÅÈðº¢Â¸üÈ¢. 
¦À¡ÐÌ½õ: 
 "Òò¾¢¿ÂÉì ÌÇ¢÷îº¢ âÃ¢ôÒ ¦ÁöôÒÇ¸ï 
 ºòÐÅí ¸ó¾¢ É¢Â¢Ç¨Á - ¦Áò¾×ñ¼¡í 
 ¸ñ§½¡ö ¦ºÅ¢§e¡ö ¸À¡ÄÅÆø ¸¡º§¿¡ö 
Òñ§½¡ö §À¡¦Áñ¦½Â¡ü §À¡üÚ" 
-  Fzghlk; %ypif tFg;G 
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gad;fs;: 
 Gj;jpf;Fj; njspT, clYf;F Fspu;r;rp, cly; G+upg;G, cly; td;ik cz;lhFk;. fz;Neha;, 
fhJNeha;, jiy nfhjpg;G, nrhup rpuq;F, Gz; ePq;Fk;. 
Constituents: 
 Sesamin, Sesamolin, Phytosterol, Vitamin E, Carbohydrates 
18%, Mucilage 4%, woody fibre 4% , Fixed Oil 50 – 60% 
Indian Materia Medica, Dr.Nadkarani. 
kQ;rs; 
 jhtutpay; ngaH :     Curcuma longa Linn 
 gad;gLk; cWg;G : fpoq;F 
 Rit   : fhHg;G> ifg;G 
 jd;ik  : ntg;gk; 
gphpT   : fhHg;G 
nra;if  : kz%l;b> mfl;Ltha;tfw;wp> ntg;gKz;lhf;fp>  
<uy;Njw;wp 
nghJf;Fzk;: 
 kQ;rl;Fspjdf;F khwhj;JHf; fe;jnkhL 
 tpQ;RKf rhl;baKk; tpl;lfYe; - njhQ;rYWk; 
 Ia nkhopA klHtpaHTq; fhzhJ 
 ita kjdpy; tOj;J 
gad;fs; 
 kQ;risg; nghbj;Jg; Gz;fs; kPJ J}t> mitfs; MWk;. 
Constituents: 
 Phellandrene, an alcohol called Turmerol and Caproic acid is 
present combined with Valeric acid. 
 
Uses: 
 Juice of the fresh rhizome is applied to wound, bruises and 
leech-bites. It is used both internally and externally in skin diseases. 
 
-Indian Materia Medica, 
Dr.Nadkarani 
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 BIO – CHEMICAL ANALYSIS OF VATHAKARAPPAN  
CHOORANAM 
Preparation of the extract :  100mgs of chooranam is weighed 
accurately & placed into a clean beaker and added a few drops of 
concentrated hydrochloric acid and evaporated it well. After 
evaporation cooled the content and added a few drops of conc. 
Nitric acid and evaporated it well. After cooling the content add 
20ml of distilled water and dissolved it well. Then it is transferred to 
100ml volumetric flask and made up to 100ml with distilled water. 
Mix well filter it . Then it is taken for analysis 
QUALITATIVE ANALYSIS 
S.no Experiment Observation Inference 
1. Test for calcium 
2ml of the above prepared extract is 
taken in a clean test tube.  To this add 2 
ml of 4% ammonium oxalate solution is 
added to it. 
A white 
precipitate is 
formed 
Indicates the 
presence of 
calcium 
2. Test for sulphate 
2ml of the extract is added to 5% barium 
chloride solution. 
A white 
precipitate is 
formed 
Indicates the 
presence of 
sulphate 
3. Test for chloride 
The extract is treated with silver nitrate 
solution. 
A white 
precipitate is 
formed 
Indicates the 
presence of 
chloride 
4. Test for carbonate 
The substance is treated with 
concentrated Hcl. 
No brisk 
effervescence 
is formed 
Absence of 
carbonate 
 
 
5. 
 
 
Test for Starch 
 
No blue colour 
is formed 
 
 
Absence of 
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The extract is added with weak iodine 
solution 
starch 
 
6. Test for iron 
Ferric 
The extract is treated with concentrated 
glacial acetic acid and potassium ferro 
cyanide.                                  
No blue colour 
is formed 
Absence of 
ferric iron 
7. Test of iron  
Ferrous 
The extract is treated with concentrated 
Nitric acid and ammonium thio cynate. 
No Blood red 
colour is 
formed 
Absence of 
ferrous iron 
8. Test for phosphate 
The extract is treated with ammonium 
molybdate and concentrated nitric acid. 
No Yellow 
precipitate is 
formed 
Absence of 
phosphate 
9. Test for albumin  
The extract is treated with Esbach’s 
reagent. 
No yellow 
precipitate is 
formed 
Absence of 
albumin 
10. Test for Tannic acid 
The extract is treated with ferric 
chloride. 
No blue black 
precipitate is 
formed 
Absence of 
Tannic acid 
11. Test for unsaturation 
Potassium permanganate solution is 
added to the extract. 
It gets 
decolourised 
Indicates  the 
presence of 
unsaturated 
compound 
12. Test for the reducing sugar 
5ml of benedict’s qualitative solution is 
taken in a test tube and allowed to boil 
for 2 mts and added 8-10 drops of the 
extract and again boil it for 2 mts. 
No colour 
change occurs 
Absence of 
reducing 
sugar 
13. Test for amino acid 
One or two drops of the extract is placed 
on a filter paper and dried it  well. After 
No violet 
colour is 
formed 
Absence  of 
amino acid 
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drying, 1% Ninhydrin is sprayed over the 
same and dried it well. 
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PHARMACOLOGICAL STUDIES 
ANTI - HISTAMINIC STUDY OF VATHA KARAPPAN 
CHOORANAM 
 
Aim 
To study the Anti-histaminic effect of Vatha Karappan 
Chooranam 
 
Preparation of the test drug 
l gm of Vatha Karappan Chooranam was boiled with 20 ml of 
water for 15 minutes. 2ml of decoction was taken as the test drug. 
 
Procedure 
A guinea pig weighed about 350gms was starved for 48 hours. 
It was sacrificed by a blow on the head and external jugular vein 
was allowed to bleed. The abdomen was then cut and ileum was 
cut out and placed in a tray, which contained warm tyrode solution 
(37° C) and continuously aerated. The contents of the lumen of the 
ileum were washed and care was taken to avoid any damage to the 
gut muscle. An ileum segment having a length of about 3cm. was 
taken and tied in both ends with thread. The tissue was put in an 
organ bath and the effects of drug on histamine-induced 
contractions were recorded. 
 
Inference 
The drug Vatha Karappan Chooranam has significant anti 
histamine action. 
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ACUTE ANTI-INFLAMMATORY STUDY ON 
VATHA KARAPPAN CHOORANAM 
Aim 
To study the acute anti-inflammatory effect of Vatha 
Karappan Chooranam by Carrageenin induced hindpaw method in 
Albino rats. 
 
Materials and Methods 
 Drug Preparation 
2 gms of Vatha Karappan Chooranam was suspended in 10ml 
of distilled water with gum acacia as suspending agent. 
 
Carrageenin induced Hind Paw Method 
Six healthy albino rats weighing 80-100 gm were selected. 
The volume of each hind paw was measured by using the mercury -
plethysmograph. 
After the measurement of hind paw of all the rats, they were 
divided into three groups each containing two rats. 
First group was kept as control by giving distilled water 
lml/100 gm of body eight. The second group was given Ibuprufen 
20mg/100gm body weight and kept as standard. Third group was 
given test drug Vatha Karappan Chooranam lOOmg/lOOgm body 
weight. 
The drugs were administered orally. One hour after the drug 
administration, 0.1ml l%(w/v) of carrageenin suspension in water 
was injected in the plantar surface of Hind paw of all rats. 
 
Three hour after carrageenin injection the hind paw volume 
was measured once again. From the differences in the initial and 
final hind paw volume, the degree of the inflammation was 
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calculated by taking the volume in the untreated control group as 
100%. 
The percentage of inflammation of the other group was 
calculated. 
 
Results 
The details of the experimental results shown in the table.  
 
EFFECT OF VATHA KARAPPAN CHOORANAM 
Group Drugs 
Dose/100gm 
of body 
weight 
Initial 
Value 
Final 
Value 
Mean 
Difference 
% 
Inflam-
mation 
% 
Inhibition 
Control Water 1ml 0.65 1.5 0.85 100.00 - 
Standard Ibubrufen 20mg/1ml 0.8 0.85 0.05 6.25 93.75 
Test 
drug 
Vatha 
Karappan 
100mg/1ml 0.8 1.3 0.5 55.5 44.5 
 
Inference 
The test drug Vatha Karappan Chooranam has moderate 
acute anti inflammatory effect when compared with the standard 
drug. 
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CHRONIC ANTI-INFLAMMATORY STUDY ON VATHA 
KARAPPAN CHOORANAM 
Aim 
To evaluate the chronic anti-inflammatory effect of Vatha 
Karappan Chooranam in rats by cotton pellets granuloma method. 
Materials and method 
Drug preparation 
1 gm of Vatha Karappan Chooranam was suspended in 10ml 
of distilled water with gum acacia as suspending agent. 
Cotton pellet Granuloma method 
Procedure 
Six healthy albino rats weighing 80-100 gm were selected and 
divided into 3 groups each containing two rats. 
In this procedure the drugs were given daily for 7 days. Before 
giving the drug, cotton pellets each weighing 10 mg were prepared 
and sterilized in an autoclave for about one hour under 15 Pounds 
atmospheric pressure. 
On the day of experiment, each rat was anaesthetised with 
ether to implant 10mg of sterilized cotton pellet subcutaneously in 
the lower abdomen two on each side after making suitable incision 
and sutured carefully. 
First group was kept as control group by giving distilled water 
of lml/100gm of body weight. To the second group, the standard 
drug Ibubrufen in a dose of 20mg 100gm of body weight was given. 
The third group of animals was given tested drug Vatha 
Karappan Chooranam in a dose of 100 mg/100gm of body weight. 
On the 8th day of the experiment, all the rats were sacrificed 
and cotton pellets found to be surrounded by granulation tissue 
were removed and dried in hot air oven at 55° C to 60° C. 
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Results 
The details of the experimental results are shown in the table. 
 
EFFECT OF VATHA KARAPPAN CHOORANAM 
 
 
Group Drugs 
Dose/100gm 
of body 
weight 
Pellet 
weight of 
the 
granuloma 
% 
Inflam-
mation 
% 
Inhibition 
Control Water 1ml 250mg 100.00 - 
Standard Ibubrufen 20mg/1ml 56mg 22.4 77.6 
Test 
drug 
Vathakarappan 
Chooranam 
100mg/1ml 155mg 58 42 
 
Inference 
The test drug Vathakarappan chooranam has moderate 
chronic anti-inflammatory effect when compared with the standard 
drug. 
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ANALGESIC STUDY ON VATHA KARAPPAN 
CHOORANAM 
Aim 
To study the analgesic effect of Vathakarappan Chooranam on 
albino rats by tail flick method. 
Materials and Methods 
Preparation of the test drug 
1 gm of Vathakarappan Chooranam was suspended in 10ml of 
distilled water with gum acacia as suspending agent. This 1 ml 
contained 100 mg of the test drug. 
Equipment 
Hot water bath. 
Procedure 
Six male albino rats (weighing 80-100gms) were used in three 
groups. The animals were allowed to free access to food and water 
until they brought to the experiment. The animals, which showed the 
positive response to the stimulus within a given time, were selected 
for the study. 
After the selection of animals, which were responding to 
stimulus within 2 seconds, they were divided into 3 groups, each 
group consisting of 2 rats. 
The hot water was maintained at 55°C .The tip of the tail was 
immersed into the water bath and time was noted when rat flicked 
the tail. 
First group was given the dose of 100mg/100gm body weight of 
the animal. Second group was administrated with paracetamol at a 
dose of 20mg/100gm of body weight. Third group was given to the 1 
ml of water and kept as control. 
After the drug administration, the reaction time of each rat 
after half an hour , 1 hour and 1½  hour were noted in each group 
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(When a rat fails to flick the tail, it should not be continued beyond 8 
seconds to avoid injury) and the average was calculated. 
The results of control group, standard group and drug treated 
group were tabulated and compared. 
 
EFFECT OF VATHA  KARAPPAN CHOORANAM 
Serial 
No 
Group Name of Drugs 
Dose / 
100 
gram 
body 
weight 
Initial 
Reading 
After Drug Administration 
½ hr 
Average 
1 hr 
average 
11/2 
Average 
1. Control Water 1 ml 2.5 2.5 2.5 3.0 
2. Standard Paracetamol 
20mg 
/ 1ml 
2.5 4.0 5.0 6.5 
3. 
Test 
drug 
Vathakarappan 
Chooranam 
100 
mg / 
1 ml 
2.5 2.5 3.5 3.5 
 
Inference 
  The test drug Vathakarappan Chooranam has mild analgesic 
action. 
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A PILOT OPEN CLINICAL TRIAL OF VATHAKARAPPAN CHOORANAM  
AND AMANAKU ENNAI FOR VATHAKARAPPAN  
(ECZEMA) 
FORM  I- SELECTION PROFORMA 
1.  OP / IP No                             2.bed no    3. S.no     
 
4.  Name                 5. Age  (yr) ……………6. Gender ………… 
 
7. Marital status  1) Single    3). Widow  
 
   2) Married   4).Separated 
8.  Occupation 
9. Postal address 
    
 
10.  Complaints & duration 
 
 
 
 
 
 
11. History of present illness 
 
 
 
 
 
12.  Past history 
 
 
 
13.  Family history   1). NO            2). YES             IF YES, ……………….. 
……………………………………………………………………………………………… 
14.  Social Status 
 1)  Low Income  2) Middle Class  3) Higher Income 
HABITS           Yes (1)            No (2) 
15.    Smoker 
16.    Alcoholic 
17.   Betalnut Chewer  
 92
18.   Non – Vegetarian 
GENERAL EXAMINATION       
19.   Body Weight (kg) 
 
20.   Body Temperature (°F)         .        .   
 
23. Blood Pressure (mmHg)    
24. Pulse rate / min 
25. Heart rate / min   
26. Respiratory rate / min 
 
         
Yes (1)        No (2) 
 
27. Pallor 
28. Jaundice 
29. Clubbing 
30. Cyanosis 
31. Pedal odema 
32. Lymphadenepathy 
 
33. Engorged veins 
 
CLINICAL EXAMINATION OF SKIN 
     Right (!)     Left (2) 
34.  Site  -. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. . . 
 . . . . . . . . . . . . . . . . . . . . . . .       . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
. .  
35.  Size (Length Cm) 
. . . . . . . . . . . . . . . . . . . . . . .       . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
36.  Colour   
 
      1.Normal  2.Reddish  3. Black  4. Greyish 
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37.  Shape     
 
      1.  Irregular  2.  Round   3.  Dispersed    
 
38. Itching  
1.  No  2.Mild                 3.Moderate             4.Severe 
 
39. Wheal 
  1.Present     2.Absent 
 
40.  Eryhema 
 1.Present     2.Absent 
 
41.  Crusting 
1.Present     2.Absent 
 
42.  Lichenification 
1.Present     2.Absent 
43.  Sensation 
 1.  Normal     2.  Hypersensitive 
 
44.  Oozing - Blood   (1)  No        (2)  Mild  (3)  Moderate (4)  
Severe   
45.  Oozing  - Water  (1)  No        (2)  Mild  (3)  Moderate (4)  
Severe    
            
 YES (1)        NO(2) 
 
46.  Ulceration 
          
47.  Macule   
 
48.  Papule 
 
49.  Pustle  
 
50.  Blister 
 
51.  Vesicle    
 
52.  Pigmentation  
 
   1. No   2. Hypo   3.Hyper  4.  De- pigmentation 
 
s
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EXAMINATIONS OF VITAL ORGANS 
                                                           Normal (1)            Abnormal (2) 
 
53. CVS               
 _____________________ 
 
54.  RS       
 _____________________ 
 
55.  Abdomen      
 _____________________ 
SIDDHA ASPECTS 
56.  NILAM 
       1.   Kurinji             2.  Mullai           3.  Marutham          4 .Neithal 5.Palai 
57.  KALA IYALBU 
          1. Kaarkaalam  2.  Koothirkallam           3.   Munpanikaalam      
          4. Pinpanikaalam  5. Ilavenirkaalam         6.Muduvenirkaalam 
58.  UDAL IYALBU 
1. Vatham    2.Pitham    3.Kabam     4. Vatha Pitham       5.Vatha Kabam  
6.Pitha Kabam  7. Pitha Vatham    8. Kaba Vatham      9.Kaba Pitham 
59.  GUNA IYALBU 
 1.Sathuvam  2.Rasatham  3.Thamasam 
IYMPORIGAL 
      Normal (1)    Affected (2)   
60. Mei  
61. Vaai   
62. Kan  
63. Mookku   
64. Sevi 
 
KANMENDHIRIUM / KANMAVIDAYAM 
   Normal (1)    Affected (2)    
65. Kai        
66. Kaal 
67. Vaai  
68. Eruvaai  
69. Karuvaai  
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UYIR THATHUKKAL 
 
  VATHAM 
             Normal (1)    Affected (2) 
70. Pranan     
71. Abanan    
72. Viyanan            
73. Uthanan      
74. Samanan                              
75. Nagan    
76. Koorman   
77. Kirukaran         
78. Devathathan     
79. Dhananjeyan   
PITTHAM 
                       Normal (1)    Affected  (2) 
80. Anar pittham         
81. Ranjagam   
82. Sathagam        
83. Alosagam                
84. Prasagam 
KABAM 
                  Normal (1)    Affected  (2) 
 85. Avalambagam 
86. Kilethagam     
87. Pothagam          
88.  Tharpagam       
89. Santhigam 
 UDAL THATHUKKAL 
                           Normal (1)   Affected (2) 
90. Saaram            
91. Senneer               
92. Oon            
93. Kozhuppu            
94. Enbu             
95. Moolai           
96. Sukkilam / 
  Suronitham 
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 ENVAGAI THERVUGAL 
                 Normal (1)    Affected (2) 
97.   Naa                    
98.   Niram          
99.   Mozhi        
100. Vizhi               
101. Sparisam 
102.   Naadi  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  
MALAM 
                Normal (1)    Affected (2) 
103.    Niram     
         Yes (1)     No (2) 
104.    Nurai       
105.    Kirumi   
106.    Kalappu 
107.    Erugal         
108.    Elagal 
MOOTHIRAM 
Neerkuri  
          Normal (1)     Affected (2) 
109.  Niram   
110.  Manam         
111.  Edai        
112.  Nurai   
113.  Enjal      
   
114.  Neikuri 1.Vatha Neer  2.Pitha Neer  3. Kaba Neer 
 
 
LAB INVESTIGATIONS 
              BLOOD 
115. TC (Cells/Cumm) 
  
          DC (%)   116. N    117.L  118.M  
       119.E       120.B  
  
 ESR (mm) 121.½ Hr    122. ESR (mm) 1 Hr 
123. Hb (g%)           
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Blood Sugar (mg%) 
     124. Fasting                       125 . Post – prandial                    
 URINE 
         126. Sugar  Fasting    0. Nil           1. +   2.+ +  3. + + +  
       127.  Sugar PP   0. Nil           1. +   2.+ +  3. + + +  
128 .Admitted to trial:   
1.YES   2. NO    
129.  If Yes, S.No   130.  IP (1)           OP (2) 
131. Date Of Purgation 
132.  Date of admission to the trial  
DRUGS ISSUED FOR O.P.PATIENTS 
133.  No of Packs       ________________   
134.  Volume of Thylum  ___________ml 
135.  Date _______________  137. Signature of Doctor:_____________ 
136. Station ______________   
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A PILOT OPEN CLINICAL TRIAL OF VATHAKARAPPAN CHOORANAM  
AND AMANAKU ENNAI FOR VATHAKARAPPAN  
(ECZEMA) 
FORM - II ASSESSMENT PROFORMA 
1. IP / OP No   2. Bed no   3. S.No 
4.  Name. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
5. Date of admission  
6. Date of assessment 
7.  Day of assessment  
CLINICAL ASSESSMENT 
     Right(1)    Left(2) 
8. Site  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
9. Size (length cm) _ _ _ _ _ _ _ _ _ _ _ _  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
10. Colour   1.Normal  2.Reddish  3. Black 
 
    
4. Silvery   
 
11. Itching 1.No  2.Mild                3.Moderate            4.Severe 
 
    Present (!)   Absent (2)  
 
12. Erythema  
13. Vesicle    
14.  Pustule  
 
15. Crusting  
 
16. Lichenification  
 
17.  Scaling 
 
18.  Ulceration 
 
19.  Oozing Blood   (1)  No        (2)  Mild  (3)  Moderate          (4)  Severe   
20.  Oozing Water  (1)  No        (2)  Mild  (3)  Moderate          (4)  Severe   
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21. Hyper Pigmentation   (1). No (2). Mild   (3). Moderate 
         
 (4) Severe 
22.  Naadi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
23.  Neerkuri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
24.  Neikuri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
LAB INVESTIGATIONS 
BLOOD 
25. TC (Cells/Cumm): 
  
      DC (%):   26.N- _ _ _ _  _  _ _ _ _ _ _   27. L - _ _ _ _  _  _ _ _ _ _ _   
  28.M - _ _ _ _  _  _ _ _ _ _ _   29.E -  _ _ _ _  _  _ _ _ _ _ _   
  
ESR (mm) 30.  ½ Hr   31. 1 Hr  
32. Hb (g%)           
Blood Sugar (mg%) 
33.  Fasting            34. Post – prandial                       
  URINE   
35. Sugar  Fasting   0. Nil           1. +   2.+ +  3. + + +  
 36.  Sugar PP  0. Nil           1. +   2.+ +  3. + + +  
 
   37.  RESULT Cured (1)        Improved (2)          No Change(3)  
     Deteriorated (4) 
FOR O.P. PATIENTS 
38.  Drugs returned  
1..  No. of Packs . . . . . . . . . . . . . . . . . . 
 2.   Volume of thylum . . . . . . . . . . . . . . . ml 
39.  Drugs issued 
1..  No. of Packs . . . . . . . . . . . . . . . . . . 
 2.   Volume of thylum . . . . . . . . . . . . . . . ml 
 
40.  Date _________________   42.Signatureof Doctor:_____________ 
 
41. Station ________________    
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A PILOT OPEN CLINICAL TRIAL OF VATHAKARAPPAN CHOORANAM  
AND AMANAKU ENNAI FOR VATHAKARAPPAN  
(ECZEMA) 
CONSENT FORM 
Certificate by Investigator 
 I certify that I have disclosed all details about the study in the terms readily 
understood by the patient. 
 
Date _______________________ Signature 
_________________________ 
 
   Name____________________________ 
 
Consent by Patient 
 I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow–up 
including the laboratory investigations to be performed to monitor and safeguard 
my body functions. 
 I am aware of my right to opt out of the trial at any time during the course 
of the trial without having to give the reasons for doing so. 
 I, exercising my free power of choice, hereby give my consent to be 
included as a subject in the pilot open clinical trial of Vathakarappan Chooranam 
and Amanaku Ennai  for the management of Vathakarappan. 
 
Date __________________   Signature ________________________ 
 
      Name ___________________________ 
 
Date ____________________   Signature of Witness ______________ 
      Name__________________________ 
      Relationship _____________________ 
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